<!DOCTYPE html><html lang="en" class="__variable_b4e6c6 __variable_efa179 __variable_149e4c"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="preload" href="/patentworld/_next/static/media/636a5ac981f94f8b-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="preload" href="/patentworld/_next/static/media/bb3ef058b751a6ad-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="preload" href="/patentworld/_next/static/media/eaead17c7dbfcd5d-s.p.woff2" as="font" crossorigin="" type="font/woff2"/><link rel="stylesheet" href="/patentworld/_next/static/css/68682e2a9cafe58c.css" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="/patentworld/_next/static/chunks/webpack-9ee10b824e272683.js"/><script src="/patentworld/_next/static/chunks/fd9d1056-925430c5a4767c0e.js" async=""></script><script src="/patentworld/_next/static/chunks/2117-59af7ab1c8300ba3.js" async=""></script><script src="/patentworld/_next/static/chunks/main-app-0bb97d9eae465cd4.js" async=""></script><script src="/patentworld/_next/static/chunks/2972-6578f2e3e7dda066.js" async=""></script><script src="/patentworld/_next/static/chunks/917-12c25c540c11b06a.js" async=""></script><script src="/patentworld/_next/static/chunks/553-1b17ddc1eb6d1252.js" async=""></script><script src="/patentworld/_next/static/chunks/1530-682cb64901734b8c.js" async=""></script><script src="/patentworld/_next/static/chunks/5736-874586b50ac068d0.js" async=""></script><script src="/patentworld/_next/static/chunks/894-c5aad0a13cab70b7.js" async=""></script><script src="/patentworld/_next/static/chunks/6498-c76f40af77abdc9f.js" async=""></script><script src="/patentworld/_next/static/chunks/3796-443ac1f8abcede52.js" async=""></script><script src="/patentworld/_next/static/chunks/2598-670b146a3686bad7.js" async=""></script><script src="/patentworld/_next/static/chunks/app/chapters/biotechnology/page-f74bc9d83f064314.js" async=""></script><script src="/patentworld/_next/static/chunks/5947-0bb5c0eb14de0f0e.js" async=""></script><script src="/patentworld/_next/static/chunks/app/chapters/layout-ef7450d546bbb756.js" async=""></script><script src="/patentworld/_next/static/chunks/app/chapters/error-adaa9b1cf3e1bbaf.js" async=""></script><script src="/patentworld/_next/static/chunks/app/layout-fef62e2bdb216f51.js" async=""></script><meta name="google-site-verification" content="El4nzV7RYgAGJl6KI74cX-Hj3LNkzQamTYyudkoF0es"/><meta name="msvalidate.01" content="AFA1EA03BEF26C7EAF46830EC6A92A41"/><title>Biotech Patents Transformed by Gene Editing | PatentWorld</title><meta name="description" content="Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation."/><link rel="author" href="https://www.saeromlee.com"/><meta name="author" content="Saerom (Ronnie) Lee"/><meta name="keywords" content="patents,innovation,USPTO,patent data,biotech patents,gene editing patents,CRISPR patents,recombinant DNA,enzyme engineering,nucleic acid detection"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-image-preview:large, max-snippet:-1"/><link rel="canonical" href="https://patentworld.vercel.app/chapters/biotechnology/"/><meta property="og:title" content="Biotech Patents Transformed by Gene Editing | PatentWorld"/><meta property="og:description" content="Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation."/><meta property="og:url" content="https://patentworld.vercel.app/chapters/biotechnology/"/><meta property="og:site_name" content="PatentWorld"/><meta property="og:image" content="https://patentworld.vercel.app/og/home.png"/><meta property="og:image:width" content="1200"/><meta property="og:image:height" content="630"/><meta property="og:image:alt" content="Biotechnology &amp; Gene Editing — PatentWorld"/><meta property="og:type" content="article"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="Biotech Patents Transformed by Gene Editing | PatentWorld"/><meta name="twitter:description" content="Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation."/><meta name="twitter:image" content="https://patentworld.vercel.app/og/home.png"/><link rel="icon" href="/patentworld/icon?d08d85312a94b8a2" type="image/png" sizes="32x32"/><meta name="next-size-adjust"/><script type="application/ld+json">[{"@context":"https://schema.org","@type":"WebSite","name":"PatentWorld","description":"Interactive exploration of 9.36 million US patents granted by the USPTO from 1976 to 2025.","url":"https://patentworld.vercel.app","author":{"@type":"Person","name":"Saerom (Ronnie) Lee","jobTitle":"Assistant Professor of Management","affiliation":{"@type":"Organization","name":"The Wharton School, University of Pennsylvania"},"url":"https://www.saeromlee.com"},"about":{"@type":"Dataset","name":"US Patent Data (1976-2025)","description":"Analysis of 9.36 million US patents from PatentsView, covering technology classifications, inventor demographics, geographic distribution, citation networks, and patent quality indicators.","creator":{"@type":"Organization","name":"USPTO / PatentsView"},"temporalCoverage":"1976/2025","spatialCoverage":"United States","variableMeasured":["Patent grants per year","Technology classifications (CPC)","Inventor demographics and collaboration","Geographic distribution","Citation networks and patent quality"]},"hasPart":[{"@type":"ScholarlyArticle","name":"Patent Count","description":"Annual US patent grants (all types) increased more than five-fold from approximately 70,000 in 1976 to 374,000 in 2024, peaking at 393,000 (all types) in 2019. Average (mean) grant pendency peaked at 3.8 years in 2010 before moderating.","url":"https://patentworld.vercel.app/chapters/system-patent-count/","position":1},{"@type":"ScholarlyArticle","name":"Patent Quality","description":"Average claims per patent doubled from 9.4 to a peak of 18.9 in 2005. Forward citations rose to a peak of 6.4 in 2019. System-wide originality rose from 0.09 to 0.25 (section-level averages reached 0.45-0.55 by the 2020s) while generality fell from 0.28 to 0.15.","url":"https://patentworld.vercel.app/chapters/system-patent-quality/","position":2},{"@type":"ScholarlyArticle","name":"Patent Fields","description":"CPC sections G and H gained 30 percentage points of share over five decades, rising from 27% to 57% of all grants. The fastest digital technology classes grew by more than 1,000%. Patent grant concentration by assignee remains below conventional thresholds across CPC sections.","url":"https://patentworld.vercel.app/chapters/system-patent-fields/","position":3},{"@type":"ScholarlyArticle","name":"Convergence","description":"Multi-section patents rose from 21% to 40% of all grants by 2024. The G-H convergence pair rose from 12.5% to 37.5% of cross-section patents between 1976-1995 and 2011-2025.","url":"https://patentworld.vercel.app/chapters/system-convergence/","position":4},{"@type":"ScholarlyArticle","name":"The Language of Innovation","description":"Computing and semiconductor topics grew from 12% to 33% of all patents since 1976. Patent novelty (median entropy) rose 6.6% from 1.97 to 2.10, with an upward trend since the late 1980s.","url":"https://patentworld.vercel.app/chapters/system-language/","position":5},{"@type":"ScholarlyArticle","name":"Patent Law & Policy","description":"The Alice decision (2014) curtailed software patent eligibility, while the AIA (2011) was the most significant reform since 1952. Twenty-one legislative and judicial events from 1980 to 2025 are associated with observable shifts in filing patterns within one to two years.","url":"https://patentworld.vercel.app/chapters/system-patent-law/","position":6},{"@type":"ScholarlyArticle","name":"Public Investment","description":"Government-funded patents rose from 1,294 in 1980 to 8,359 in 2019 after the Bayh-Dole Act. HHS/NIH leads with 55,587 patents, followed by Defense (43,736) and Energy (33,994).","url":"https://patentworld.vercel.app/chapters/system-public-investment/","position":7},{"@type":"ScholarlyArticle","name":"Assignee Composition","description":"Corporate assignees grew from 94% to 99% of US patent grants. Foreign assignees surpassed US-based assignees around 2007. Japan accounts for 1.45 million US patents since 1976.","url":"https://patentworld.vercel.app/chapters/org-composition/","position":8},{"@type":"ScholarlyArticle","name":"Organizational Patent Count","description":"IBM leads with 161,888 cumulative grants. Samsung peaked at 9,716 annual grants in 2024. The top 100 organizations hold 32-39% of corporate patents.","url":"https://patentworld.vercel.app/chapters/org-patent-count/","position":9},{"@type":"ScholarlyArticle","name":"Organizational Patent Quality","description":"Amazon holds the highest blockbuster rate at 6.7%. Microsoft leads in average citations at 30.7. Citation half-lives range from 6.3 years (Huawei) to 14.3 years.","url":"https://patentworld.vercel.app/chapters/org-patent-quality/","position":10},{"@type":"ScholarlyArticle","name":"Patent Portfolio","description":"50 companies (248 company-decade observations) cluster into 8 industry groups by patent portfolio similarity. Portfolio diversity rose across leading firms, with Mitsubishi Electric reaching a peak Shannon entropy of 7.1 across 287 CPC subclasses. 51 technology pivots detected across 20 companies, which can precede strategic shifts that later become publicly visible.","url":"https://patentworld.vercel.app/chapters/org-patent-portfolio/","position":11},{"@type":"ScholarlyArticle","name":"Interactive Company Profiles","description":"Interactive dashboards for each organization across five analytical dimensions: output trajectories, technology portfolios, citation quality, innovation strategy radar, and grant lag trends. Search and compare any assignee in the dataset.","url":"https://patentworld.vercel.app/chapters/org-company-profiles/","position":12},{"@type":"ScholarlyArticle","name":"Top Inventors","description":"The top 5% of inventors (by cumulative output) account for 63.2% of all patents. Their annual share rose from 26% to 60% between 1976 and 2025. The most prolific inventor holds 6,709 patents. Citation impact ranges from 10 to 965 average citations among top 100.","url":"https://patentworld.vercel.app/chapters/inv-top-inventors/","position":13},{"@type":"ScholarlyArticle","name":"Generalist vs. Specialist","description":"Specialist inventors rose from 20% to 48% of the inventor workforce. Generalists earn 9.3 forward citations per patent vs. 8.2 for specialists and score 0.212 on originality vs. 0.165.","url":"https://patentworld.vercel.app/chapters/inv-generalist-specialist/","position":14},{"@type":"ScholarlyArticle","name":"Serial Inventors vs. New Entrants","description":"Annual first-time inventor entries peaked at 140,490 in 2019. Only 37-51% of inventors survive past five career years. Productivity rises from 1.4 to 2.1 patents per year.","url":"https://patentworld.vercel.app/chapters/inv-serial-new/","position":15},{"@type":"ScholarlyArticle","name":"Gender and Patenting","description":"Female inventor share rose from 2.8% in 1976 to 14.9% in 2025 (through September). All-male teams average 14.2 forward citations, mixed-gender teams 12.6, and all-female teams 9.5. Chemistry leads cumulative female representation at 14.6% (1976-2025), reaching 23.4% in the most recent period.","url":"https://patentworld.vercel.app/chapters/inv-gender/","position":16},{"@type":"ScholarlyArticle","name":"Team Size and Collaboration","description":"Average patent team size increased from 1.7 to 3.2 inventors, while the solo-inventor share fell from 58% to 23% by 2025. Teams of 7+ average 16.7 claims per patent vs. 11.6 for solo inventors.","url":"https://patentworld.vercel.app/chapters/inv-team-size/","position":17},{"@type":"ScholarlyArticle","name":"Domestic Geography","description":"California accounts for 23.6% of all US patent grants, producing 992,708 patents -- more than the bottom 30 states combined. States exhibit distinctive specialization: Michigan devotes 20.1% to Mechanical Engineering vs. California's 65.1% in Physics and Electricity.","url":"https://patentworld.vercel.app/chapters/geo-domestic/","position":18},{"@type":"ScholarlyArticle","name":"International Geography","description":"Japan leads foreign filings with 1.45 million US patents, while China grew from 299 filings in 2000 to 30,695 in 2024. The US leads with approximately 164,000 patents granted cumulatively during the 2020s (by assignee country) and 18.4 average claims, while rapidly growing origins exhibit lower claims, suggesting a quality-quantity tradeoff.","url":"https://patentworld.vercel.app/chapters/geo-international/","position":19},{"@type":"ScholarlyArticle","name":"Organizational Mechanics","description":"11 of 20 major filers keep exploration below 5%. Balanced firms produce blockbusters at 2.3x the rate of specialists. 618 organizations form distinct industry clusters in the co-patenting network.","url":"https://patentworld.vercel.app/chapters/mech-organizations/","position":20},{"@type":"ScholarlyArticle","name":"Inventor Mechanics","description":"632 prolific inventors form 1,236 co-invention ties. 143,524 inventor movements (consecutive patents at different assignees within 5 years) flow among 50 organizations. International mobility rose from 1.3% to 5.1%, with the US involved in 77.6% of all cross-border flows.","url":"https://patentworld.vercel.app/chapters/mech-inventors/","position":21},{"@type":"ScholarlyArticle","name":"Geographic Mechanics","description":"International co-invention increased from 1.0% in 1976 to 10.0% in 2025 (through September). US-China co-invention grew from 77 patents in 2000 to 2,749 in 2024.","url":"https://patentworld.vercel.app/chapters/mech-geography/","position":22},{"@type":"ScholarlyArticle","name":"3D Printing & Additive Manufacturing","description":"Top-four-firm concentration in 3D printing patents declined from 36% in 2005 to 11% by 2024, as the expiration of key FDM patents in 2009 opened the field to broad-based competition. Later entrants (2010s cohort) patent at 11.2 patents per year compared to 8.3 for 1990s entrants.","url":"https://patentworld.vercel.app/chapters/3d-printing/","position":23},{"@type":"ScholarlyArticle","name":"Agricultural Technology","description":"Agricultural technology patent velocity nearly quadrupled from 7.4 patents per year (1970s entrants) to 32.9 (2000s entrants), coinciding with the precision agriculture revolution. Top-four concentration declined from 46.7% in 2014 to 32.8% by 2025.","url":"https://patentworld.vercel.app/chapters/agricultural-technology/","position":24},{"@type":"ScholarlyArticle","name":"Artificial Intelligence","description":"AI patent grants grew 5.7-fold from 5,201 in 2012 to 29,624 in 2023, reaching 9.4% of all US patent grants. IBM leads with 16,781 AI patents, followed by Google (7,775) and Samsung (6,195).","url":"https://patentworld.vercel.app/chapters/ai-patents/","position":25},{"@type":"ScholarlyArticle","name":"Autonomous Vehicles & ADAS","description":"Autonomous vehicle patent velocity rose from 15.9 patents per year (1990s entrants) to 28.6 (2010s entrants), a 1.8-fold increase. Subfield diversity reached near-maximum entropy of 0.97 by 2025. Toyota, Honda, Ford, and Waymo lead the field.","url":"https://patentworld.vercel.app/chapters/autonomous-vehicles/","position":26},{"@type":"ScholarlyArticle","name":"Biotechnology & Gene Editing","description":"Biotechnology achieved the lowest top-four concentration among all advanced technology domains studied, declining from 13.5% in 2007 to 4.6% by 2025. Subfield diversity tripled from 0.32 in 1976 to 0.94 by 2025, reflecting successive waves from recombinant DNA to CRISPR-Cas9.","url":"https://patentworld.vercel.app/chapters/biotechnology/","position":27},{"@type":"ScholarlyArticle","name":"Blockchain & Decentralized Systems","description":"Blockchain patent filings peaked in 2022 and subsequently declined, the only advanced technology domain in the study to reverse course. Top-four concentration rose to 26.3% during the 2018 boom before declining to 14.0% by 2024.","url":"https://patentworld.vercel.app/chapters/blockchain/","position":28},{"@type":"ScholarlyArticle","name":"Cybersecurity","description":"Cybersecurity top-four concentration declined from 32.4% in 1980 to 9.4% by 2025, reflecting broad-based entry across the field. Patent velocity reached 105.8 patents per year for 2010s entrants, a 1.4-fold increase over 1970s entrants. Network security surpassed cryptography as the dominant subfield around 2003.","url":"https://patentworld.vercel.app/chapters/cybersecurity/","position":29},{"@type":"ScholarlyArticle","name":"Digital Health & Medical Devices","description":"Digital health patent velocity jumped 3.4-fold from 22.5 patents per year (1970s entrants) to 77.5 (2010s entrants). Philips (2,909 patents), Medtronic (2,302), and Intuitive Surgical (1,994) lead the field. Subfield diversity rose from 0.48 in 1976 to 0.92 by 2025.","url":"https://patentworld.vercel.app/chapters/digital-health/","position":30},{"@type":"ScholarlyArticle","name":"Green Innovation","description":"Green patents show a 1.8-fold velocity increase from 1970s to 2000s entrants (68 to 122 patents per year). Battery and EV patents reached 7,363 and 5,818 grants respectively by 2024, surpassing renewable energy at 3,453. Samsung (13,771), Toyota (12,636), and GE (10,812) lead.","url":"https://patentworld.vercel.app/chapters/green-innovation/","position":31},{"@type":"ScholarlyArticle","name":"Quantum Computing","description":"Quantum computing remains among the most concentrated advanced technology domains alongside agricultural technology, with the top four firms holding 28.4% of patents in 2025 (through September), down from 76.9% in 2003. It is the only domain where early entrants (1990s cohort) patent faster than later entrants, reflecting high hardware IP barriers.","url":"https://patentworld.vercel.app/chapters/quantum-computing/","position":32},{"@type":"ScholarlyArticle","name":"Semiconductors","description":"Semiconductor patents uniquely exhibit rising concentration, with top-four-firm share increasing from 11.3% in 1977 to 32.6% in 2023 — the only advanced technology domain showing sustained consolidation. Entry velocity plateaued at 197 patents per year for both 1990s and 2010s cohorts.","url":"https://patentworld.vercel.app/chapters/semiconductors/","position":33},{"@type":"ScholarlyArticle","name":"Space Technology","description":"Space technology top-four concentration fluctuated between 4.9% and 36.7%, reflecting the transition from government-dominated to commercial-driven innovation. Boeing, ViaSat, and Lockheed Martin lead, with satellite communications now the dominant subfield.","url":"https://patentworld.vercel.app/chapters/space-technology/","position":34}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://patentworld.vercel.app"}]}]</script><script src="/patentworld/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule=""></script></head><body class="font-sans"><script>((e,t,r,n,o,a,l,u)=>{let i=document.documentElement,s=["light","dark"];function c(t){(Array.isArray(e)?e:[e]).forEach(e=>{let r="class"===e,n=r&&a?o.map(e=>a[e]||e):o;r?(i.classList.remove(...n),i.classList.add(a&&a[t]?a[t]:t)):i.setAttribute(e,t)}),u&&s.includes(t)&&(i.style.colorScheme=t)}if(n)c(n);else try{let e=localStorage.getItem(t)||r,n=l&&"system"===e?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":e;c(n)}catch(e){}})("class","theme","system",null,["light","dark"],null,true,true)</script><a href="#main-content" class="sr-only focus:not-sr-only focus:fixed focus:top-1 focus:left-1 focus:z-[80] focus:rounded-md focus:bg-primary focus:px-4 focus:py-2 focus:text-primary-foreground focus:text-sm">Skip to content</a><div class="fixed top-0 left-0 right-0 z-[60] h-0.5" aria-hidden="true"><div class="h-full bg-primary transition-[width] duration-150 ease-out" style="width:0%"></div></div><header class="sticky top-0 z-50 border-b bg-background/80 backdrop-blur-sm"><div class="mx-auto flex h-14 max-w-7xl items-center justify-between px-4 lg:px-8"><a class="flex items-center gap-2 font-serif text-lg font-bold focus:outline-none focus:ring-2 focus:ring-primary rounded-md" href="/patentworld/"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chart-column h-5 w-5" aria-hidden="true"><path d="M3 3v16a2 2 0 0 0 2 2h16"></path><path d="M18 17V9"></path><path d="M13 17V5"></path><path d="M8 17v-3"></path></svg>PatentWorld</a><nav aria-label="Main navigation" class="hidden items-center gap-4 md:flex"><a class="rounded-md px-3 py-1.5 text-sm text-muted-foreground hover:bg-accent hover:text-foreground transition-colors focus:outline-none focus:ring-2 focus:ring-primary" href="/patentworld/explore/">Explore</a><a class="rounded-md px-3 py-1.5 text-sm text-muted-foreground hover:bg-accent hover:text-foreground transition-colors focus:outline-none focus:ring-2 focus:ring-primary" href="/patentworld/methodology/">Methodology</a><a class="rounded-md px-3 py-1.5 text-sm text-muted-foreground hover:bg-accent hover:text-foreground transition-colors focus:outline-none focus:ring-2 focus:ring-primary" href="/patentworld/about/">About</a></nav><div class="flex items-center gap-2"><div class="h-9 w-9"></div><button class="md:hidden flex items-center justify-center h-9 w-9 rounded-md hover:bg-accent transition-colors focus:outline-none focus:ring-2 focus:ring-primary" aria-label="Open navigation menu"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-menu h-5 w-5" aria-hidden="true"><path d="M4 5h16"></path><path d="M4 12h16"></path><path d="M4 19h16"></path></svg></button></div></div></header><main id="main-content" class="min-h-screen"><div class="relative"><aside class="hidden lg:block fixed left-0 top-14 h-[calc(100vh-3.5rem)] w-64 border-r bg-background overflow-y-auto p-4"><div class="text-xs font-medium uppercase tracking-wider text-muted-foreground mb-3">Chapters</div><nav class="flex flex-col gap-0.5"><div><div class="mt-4 first:mt-0 mb-1 px-3 text-[10px] font-semibold uppercase tracking-widest text-muted-foreground/60">Act <!-- -->1<!-- --> — <!-- -->The System</div><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/system-patent-count/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">01</span><span>Patent Count</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/system-patent-quality/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">02</span><span>Patent Quality</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/system-patent-fields/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">03</span><span>Patent Fields</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/system-convergence/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">04</span><span>Convergence</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/system-language/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">05</span><span>The Language of Innovation</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/system-patent-law/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">06</span><span>Patent Law &amp; Policy</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/system-public-investment/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">07</span><span>Public Investment</span></a></div><div><div class="mt-4 first:mt-0 mb-1 px-3 text-[10px] font-semibold uppercase tracking-widest text-muted-foreground/60">Act <!-- -->2<!-- --> — <!-- -->The Organizations</div><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/org-composition/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">08</span><span>Assignee Composition</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/org-patent-count/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">09</span><span>Organizational Patent Count</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/org-patent-quality/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">10</span><span>Organizational Patent Quality</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/org-patent-portfolio/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">11</span><span>Patent Portfolio</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/org-company-profiles/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">12</span><span>Interactive Company Profiles</span></a></div><div><div class="mt-4 first:mt-0 mb-1 px-3 text-[10px] font-semibold uppercase tracking-widest text-muted-foreground/60">Act <!-- -->3<!-- --> — <!-- -->The Inventors</div><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/inv-top-inventors/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">13</span><span>Top Inventors</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/inv-generalist-specialist/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">14</span><span>Generalist vs. Specialist</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/inv-serial-new/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">15</span><span>Serial Inventors vs. New Entrants</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/inv-gender/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">16</span><span>Gender and Patenting</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/inv-team-size/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">17</span><span>Team Size and Collaboration</span></a></div><div><div class="mt-4 first:mt-0 mb-1 px-3 text-[10px] font-semibold uppercase tracking-widest text-muted-foreground/60">Act <!-- -->4<!-- --> — <!-- -->The Geography</div><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/geo-domestic/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">18</span><span>Domestic Geography</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/geo-international/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">19</span><span>International Geography</span></a></div><div><div class="mt-4 first:mt-0 mb-1 px-3 text-[10px] font-semibold uppercase tracking-widest text-muted-foreground/60">Act <!-- -->5<!-- --> — <!-- -->The Mechanics</div><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/mech-organizations/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">20</span><span>Organizational Mechanics</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/mech-inventors/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">21</span><span>Inventor Mechanics</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/mech-geography/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">22</span><span>Geographic Mechanics</span></a></div><div><div class="mt-4 first:mt-0 mb-1 px-3 text-[10px] font-semibold uppercase tracking-widest text-muted-foreground/60">Act <!-- -->6<!-- --> — <!-- -->Deep Dives</div><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/3d-printing/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">23</span><span>3D Printing &amp; Additive Manufacturing</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/agricultural-technology/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">24</span><span>Agricultural Technology</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/ai-patents/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">25</span><span>Artificial Intelligence</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/autonomous-vehicles/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">26</span><span>Autonomous Vehicles &amp; ADAS</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary bg-accent text-foreground font-medium" href="/patentworld/chapters/biotechnology/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">27</span><span>Biotechnology &amp; Gene Editing</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/blockchain/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">28</span><span>Blockchain &amp; Decentralized Systems</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/cybersecurity/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">29</span><span>Cybersecurity</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/digital-health/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">30</span><span>Digital Health &amp; Medical Devices</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/green-innovation/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">31</span><span>Green Innovation</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/quantum-computing/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">32</span><span>Quantum Computing</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/semiconductors/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">33</span><span>Semiconductors</span></a><a class="flex items-start gap-3 rounded-md px-3 py-2 text-sm transition-colors focus:outline-none focus:ring-2 focus:ring-primary text-muted-foreground hover:bg-accent/50 hover:text-foreground" href="/patentworld/chapters/space-technology/"><span class="mt-0.5 shrink-0 font-mono text-xs text-muted-foreground">34</span><span>Space Technology</span></a></div></nav></aside><div class="lg:ml-64"><div class="mx-auto max-w-5xl px-4 py-12 lg:px-8"><nav aria-label="Breadcrumb" class="mb-4 text-sm text-muted-foreground"><ol class="flex items-center gap-1 flex-wrap"><li class="flex items-center gap-1"><a class="hover:text-foreground transition-colors focus:outline-none focus:ring-2 focus:ring-primary rounded-md" href="/patentworld/">Home</a></li><li class="flex items-center gap-1"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-right h-3 w-3 shrink-0" aria-hidden="true"><path d="m9 18 6-6-6-6"></path></svg><span class="truncate">Act <!-- -->6<!-- -->: <!-- -->Deep Dives</span></li><li class="flex items-center gap-1" aria-current="page"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-right h-3 w-3 shrink-0" aria-hidden="true"><path d="m9 18 6-6-6-6"></path></svg><span class="text-foreground font-medium truncate">Biotechnology &amp; Gene Editing</span></li></ol></nav><article itemScope="" itemType="https://schema.org/ScholarlyArticle"><script type="application/ld+json">[{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Biotech Patents Transformed by Gene Editing","description":"Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation.","author":{"@type":"Person","name":"Saerom (Ronnie) Lee","jobTitle":"Assistant Professor of Management","affiliation":{"@type":"Organization","name":"The Wharton School, University of Pennsylvania"}},"publisher":{"@type":"Organization","name":"University of Pennsylvania","url":"https://www.upenn.edu"},"datePublished":"2025-01-01","dateModified":"2026-02-14","mainEntityOfPage":"https://patentworld.vercel.app/chapters/biotechnology/","image":"https://patentworld.vercel.app/og/home.png","keywords":"biotech patents, gene editing patents, CRISPR patents, recombinant DNA, enzyme engineering, nucleic acid detection","isPartOf":{"@type":"WebSite","name":"PatentWorld","url":"https://patentworld.vercel.app"},"about":{"@type":"Dataset","name":"US Patent Data (1976-2025)","description":"Analysis of 9.36 million US utility patents from PatentsView / USPTO.","temporalCoverage":"1976/2025"}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://patentworld.vercel.app"},{"@type":"ListItem","position":2,"name":"Act 6: Deep Dives","item":"https://patentworld.vercel.app/#acts"},{"@type":"ListItem","position":3,"name":"Biotechnology & Gene Editing","item":"https://patentworld.vercel.app/chapters/biotechnology/"}]}]</script><div><header class="relative mb-10 -mx-4 px-4 py-8 sm:-mx-6 sm:px-6 rounded-lg overflow-hidden" style="background:radial-gradient(ellipse at top left, rgba(59,130,246,0.08) 0%, transparent 70%)"><div class="font-mono text-sm uppercase tracking-widest text-muted-foreground mb-3">Chapter <!-- -->27</div><h1 class="font-serif text-4xl font-bold tracking-tight sm:text-5xl">Biotechnology &amp; Gene Editing</h1><p class="mt-3 text-lg text-muted-foreground">Engineering life at the molecular level</p><div class="mt-4 h-0.5 w-16 rounded-full bg-primary/40" aria-hidden="true"></div></header><aside class="my-4 rounded-lg border border-border/60 bg-muted/20"><button class="flex w-full items-center gap-2 px-4 py-2.5 text-left text-xs font-medium text-muted-foreground transition-colors hover:text-foreground" aria-expanded="false"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-settings2 lucide-settings-2 h-3.5 w-3.5" aria-hidden="true"><path d="M14 17H5"></path><path d="M19 7h-9"></path><circle cx="17" cy="17" r="3"></circle><circle cx="7" cy="7" r="3"></circle></svg><span class="uppercase tracking-wider">Measurement details</span><span class="ml-auto"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-down h-3.5 w-3.5" aria-hidden="true"><path d="m6 9 6 6 6-6"></path></svg></span></button></aside><aside aria-label="Key findings from PatentWorld" class="fade-in-section my-8 rounded-lg border-l-4 border-blue-500 bg-blue-50/50 p-5 dark:bg-blue-950/20 "><h2 class="mb-3 text-sm font-semibold uppercase tracking-wide text-blue-700 dark:text-blue-400">Key Findings</h2><ol class="list-decimal space-y-2 pl-5 text-sm leading-relaxed text-foreground/90"><li>Biotechnology patenting has grown substantially since the 1980s, following the Bayh-Dole Act (1980), which permitted universities to patent federally funded inventions.</li><li>The completion of the Human Genome Project in 2003 and the publication of CRISPR-Cas9 gene editing in 2012 represent inflection points that reshaped the composition of biotech patents, shifting activity toward genomic technologies and precision gene editing.</li><li>Unlike AI patenting, which is dominated by technology firms, biotech patents are concentrated among research universities (University of California, Harvard, Stanford), agricultural biotech firms (Monsanto, Pioneer Hi-Bred, DuPont), and enzyme companies (Novozymes), reflecting the distinct institutional structure of life sciences innovation.</li><li>The development and patenting of mRNA vaccine technology during the COVID-19 pandemic occurred at an accelerated pace relative to typical biotech development timelines.</li></ol><p class="mt-3 text-xs text-muted-foreground">Source: PatentWorld.</p></aside><aside class="my-8 rounded-lg border bg-muted/30 p-5"><h2 class="mb-2 text-sm font-semibold uppercase tracking-wide text-muted-foreground">Executive Summary</h2><p class="text-sm leading-relaxed">Biotechnology patenting in the United States reflects a half-century transformation in how society harnesses molecular biology for commercial and therapeutic purposes. The Bayh-Dole Act of 1980 coincided with a substantial expansion of university-originated patents, while the completion of the Human Genome Project in 2003 and the discovery of CRISPR-Cas9 gene editing in 2012 coincided with successive waves of inventive activity. The institutional landscape of biotech patenting differs markedly from domains such as artificial intelligence: research universities, agricultural biotech firms, enzyme companies, and life sciences tools makers play prominent roles, and the ethical and regulatory dimensions of gene editing technology create unique constraints on how patents translate into products. The COVID-19 pandemic further demonstrated the strategic importance of biotech patent portfolios, as mRNA vaccine technology moved from laboratory concept to global deployment in under a year. This chapter traces the growth, composition, and organizational structure of biotechnology patenting across the full span of the modern patent system.</p></aside><section class="fade-in-section prose-custom my-8 max-w-prose text-lg leading-relaxed text-foreground/90 "><p>Having examined <a class="underline decoration-muted-foreground/50 hover:decoration-foreground transition-colors" href="/patentworld/chapters/autonomous-vehicles/">autonomous vehicles</a> and the convergence of AI, sensing, and control systems in transportation, this chapter turns to biotechnology, a domain defined by fundamentally different innovation dynamics rooted in molecular biology and regulatory constraints.</p><p>Biotechnology occupies a distinctive position within the patent system. Unlike most technology domains where the path from invention to commercialization is relatively direct, biotech patents frequently emerge from basic scientific research conducted at universities and government laboratories, traverse lengthy regulatory approval processes, and raise profound ethical questions about the boundaries of patentable subject matter. This chapter examines the trajectory of biotechnology and gene editing patents -- from the recombinant DNA revolution of the 1970s through the genomic era and the current frontier of precision gene editing.</p></section><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>Biotechnology patent activity serves as a barometer of the life sciences innovation ecosystem. The field has been shaped by a series of landmark scientific breakthroughs -- recombinant DNA technology, polymerase chain reaction, the Human Genome Project, and CRISPR-Cas9 -- each of which generated distinctive waves of patenting activity. The interplay between academic discovery, commercial development, and regulatory oversight makes biotech patenting uniquely complex among technology domains.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="growth-trajectory" data-section-label="Growth Trajectory"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Growth Trajectory</span><div class="flex-grow border-t border-border"></div></div><figure id="fig-biotech-annual-count" aria-labelledby="fig-biotech-annual-count-heading" aria-describedby="fig-biotech-annual-count-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-annual-count-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotechnology Patent Filings Have Grown Substantially Since the 1980s, With Notable Fluctuations</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Annual count of utility patents classified under biotechnology-related CPC codes, tracking the growth trajectory of biotech patenting.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Annual count of utility patents classified under biotechnology-related CPC codes, tracking the growth trajectory of biotech patenting.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotechnology Patent Filings Have Grown Substantially Since the 1980s, With Notable Fluctuations" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Annual count of utility patents classified under biotechnology-related CPC codes, 1976-2025. The growth trajectory reflects successive waves following the Bayh-Dole Act (1980), the Human Genome Project completion (2003), and the CRISPR-Cas9 publication (2012). Grant year shown. Application dates are typically 2–3 years earlier.</p></noscript></div><figcaption id="fig-biotech-annual-count-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Annual count of utility patents classified under biotechnology-related CPC codes, 1976-2025. The growth trajectory reflects successive waves following the Bayh-Dole Act (1980), the Human Genome Project completion (2003), and the CRISPR-Cas9 publication (2012). Grant year shown. Application dates are typically 2–3 years earlier.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The sustained growth of biotech patents reflects the expanding commercial potential of molecular biology, with each major scientific breakthrough coinciding with a new wave of inventive activity.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>Biotechnology patent filings have exhibited substantial growth since the early 1980s, following the Bayh-Dole Act which enabled universities to patent inventions arising from federally funded research. This legislative change was consequential for the life sciences, creating a direct pathway from academic laboratories to commercial development. The completion of the Human Genome Project in 2003 accelerated genomic patenting, while the publication of CRISPR-Cas9 gene editing technology in 2012 opened a new frontier of precision genetic engineering.</p></div></aside><figure id="fig-biotech-entrant-incumbent" aria-labelledby="fig-biotech-entrant-incumbent-heading" aria-describedby="fig-biotech-entrant-incumbent-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-entrant-incumbent-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotechnology Patenting Shows Persistent Incumbent Strength With Steady Entrant Inflows</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Annual patent counts from entrant and incumbent assignees in the biotechnology domain.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Annual patent counts from entrant and incumbent assignees in the biotechnology domain.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotechnology Patenting Shows Persistent Incumbent Strength With Steady Entrant Inflows" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Entrants are organizations filing their first biotech patent in a given year; incumbents are those with prior filings.</p></noscript></div><figcaption id="fig-biotech-entrant-incumbent-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Entrants are organizations filing their first biotech patent in a given year; incumbents are those with prior filings.</figcaption><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><figure id="fig-biotech-share" aria-labelledby="fig-biotech-share-heading" aria-describedby="fig-biotech-share-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-share-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotechnology&#x27;s Share of Total Patents Reflects the Centrality of Life Sciences Innovation</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Biotech patents as a percentage of all utility patents, showing the evolving weight of life sciences in the innovation system.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Biotech patents as a percentage of all utility patents, showing the evolving weight of life sciences in the innovation system.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotechnology&#x27;s Share of Total Patents Reflects the Centrality of Life Sciences Innovation" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Percentage of all utility patents classified under biotechnology-related CPC codes. Biotech&#x27;s share has fluctuated over time, reflecting how molecular biology has become a stable but significant component of the patent system.</p></noscript></div><figcaption id="fig-biotech-share-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Percentage of all utility patents classified under biotechnology-related CPC codes. Biotech&#x27;s share has fluctuated over time, reflecting how molecular biology has become a stable but significant component of the patent system.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The growing share of biotech patents among all patents demonstrates that life sciences innovation is not merely tracking overall patent expansion but represents a genuine structural shift in the composition of inventive activity reflected in the USPTO record.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><div class="relative my-12 flex items-center scroll-mt-20" id="biotech-subfields" data-section-label="Biotech Subfields"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Biotech Subfields</span><div class="flex-grow border-t border-border"></div></div><figure id="fig-biotech-subfields" aria-labelledby="fig-biotech-subfields-heading" aria-describedby="fig-biotech-subfields-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-subfields-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Recombinant DNA and Expression Vectors Are Among the Largest Growing Biotech Subfields</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Patent counts by biotechnology subfield (gene editing, recombinant DNA, enzyme engineering, and other subfields) over time, based on CPC classifications.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Patent counts by biotechnology subfield (gene editing, recombinant DNA, enzyme engineering, and other subfields) over time, based on CPC classifications.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Recombinant DNA and Expression Vectors Are Among the Largest Growing Biotech Subfields" style="height:650px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Patent counts by biotechnology subfield over time, based on CPC classifications. The data reveal substantial growth in recombinant DNA and expression vectors since 2012, alongside the expansion of gene editing and nucleic acid detection methods.</p></noscript></div><figcaption id="fig-biotech-subfields-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Patent counts by biotechnology subfield over time, based on CPC classifications. The data reveal substantial growth in recombinant DNA and expression vectors since 2012, alongside the expansion of gene editing and nucleic acid detection methods.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The subfield composition of biotech patents has shifted substantially since 2012, with recombinant DNA technology continuing to grow substantially, while gene editing and expression vector technologies have also expanded considerably.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The composition of biotechnology patents has evolved substantially over the past five decades. Early biotech patenting was concentrated in enzyme engineering. Since 2012, gene editing and modification patents have expanded substantially, associated with the development of CRISPR-Cas9 technology, which enabled more precise genomic alterations. Enzyme engineering and nucleic acid detection have also experienced considerable growth, reflecting advances in directed evolution (recognized by the 2018 Nobel Prize in Chemistry) and the proliferation of PCR-based and advanced sequencing diagnostic platforms, particularly during the COVID-19 pandemic.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="leading-organizations" data-section-label="Leading Organizations"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Leading Organizations</span><div class="flex-grow border-t border-border"></div></div><figure id="fig-biotech-top-assignees" aria-labelledby="fig-biotech-top-assignees-heading" aria-describedby="fig-biotech-top-assignees-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-top-assignees-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Research Universities and Agricultural Biotech Firms Dominate Biotechnology Patenting</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Organizations ranked by total biotechnology patent count, showing the institutional landscape of life sciences innovation.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Organizations ranked by total biotechnology patent count, showing the institutional landscape of life sciences innovation.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Research Universities and Agricultural Biotech Firms Dominate Biotechnology Patenting" style="height:1400px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Organizations ranked by total biotechnology-related patents, 1976-2025. The data reveal a distinctive institutional mix: research universities (University of California, Harvard, Stanford), agricultural biotech firms (Monsanto, Pioneer Hi-Bred, DuPont), and enzyme companies (Novozymes) dominate the rankings, reflecting the diverse origins of biotech innovation.</p></noscript></div><figcaption id="fig-biotech-top-assignees-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Organizations ranked by total biotechnology-related patents, 1976-2025. The data reveal a distinctive institutional mix: research universities (University of California, Harvard, Stanford), agricultural biotech firms (Monsanto, Pioneer Hi-Bred, DuPont), and enzyme companies (Novozymes) dominate the rankings, reflecting the diverse origins of biotech innovation.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The organizational landscape of biotech patenting differs markedly from AI, where large technology firms dominate. In biotechnology, research universities, agricultural biotech firms, enzyme companies, and life sciences tools makers are the major patent holders, reflecting the field&#x27;s diverse institutional roots.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The leading biotechnology patent holders reflect the distinctive institutional structure of life sciences innovation. Unlike artificial intelligence, where technology corporations overwhelmingly dominate, biotech patenting features a diverse organizational landscape. Agricultural biotech firms such as Monsanto, Pioneer Hi-Bred, and DuPont are among the top patent holders, alongside enzyme companies like Novozymes. Research universities -- empowered by the Bayh-Dole Act -- hold prominent positions, with the University of California ranking first overall, and Harvard and Stanford also in the top ten. This mix of agricultural biotech, life sciences tools companies, and academic institutions is a defining feature of the biotech innovation ecosystem, with technology transfer offices serving as critical intermediaries between academic discovery and commercial application.</p></div></aside><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The ranking data illustrate how successive technological breakthroughs have reshaped organizational leadership in biotech patenting. The completion of the Human Genome Project was followed by a wave of genomic patenting that benefited firms positioned in sequencing and diagnostics. The CRISPR revolution after 2012 created new competitive dynamics, with specialized gene editing companies and academic institutions claiming significant patent positions. The COVID-19 pandemic further disrupted rankings as mRNA platform companies rapidly expanded their patent portfolios. These shifts underscore how, in biotechnology, scientific breakthroughs can rapidly alter the organizational hierarchy of innovation.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="top-inventors" data-section-label="Top Inventors"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Top Inventors</span><div class="flex-grow border-t border-border"></div></div><figure id="fig-biotech-top-inventors" aria-labelledby="fig-biotech-top-inventors-heading" aria-describedby="fig-biotech-top-inventors-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-top-inventors-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">The Most Prolific Biotech Inventors Reflect the Field&#x27;s Deep Connection to Academic Research and Pharmaceutical R&amp;D</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Primary inventors ranked by total biotechnology patent count, illustrating the distribution of individual inventive output in the life sciences.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Primary inventors ranked by total biotechnology patent count, illustrating the distribution of individual inventive output in the life sciences.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: The Most Prolific Biotech Inventors Reflect the Field&#x27;s Deep Connection to Academic Research and Pharmaceutical R&amp;D" style="height:1400px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Primary inventors ranked by total biotechnology-related patents, 1976-2025. The distribution reveals that prolific biotech inventors are frequently affiliated with universities and pharmaceutical firms, reflecting the academic origins of many biotech breakthroughs.</p></noscript></div><figcaption id="fig-biotech-top-inventors-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Primary inventors ranked by total biotechnology-related patents, 1976-2025. The distribution reveals that prolific biotech inventors are frequently affiliated with universities and pharmaceutical firms, reflecting the academic origins of many biotech breakthroughs.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The concentration of biotech patenting among prolific inventors affiliated with universities and pharmaceutical companies highlights the field&#x27;s dependence on deep scientific expertise and long-term research programs.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The most prolific biotechnology inventors are characteristically affiliated with research universities and pharmaceutical companies that maintain long-term programs in genetic engineering, molecular biology, and drug development. Unlike AI, where the most productive inventors tend to cluster in corporate research laboratories of technology firms, biotech invention exhibits a stronger connection to academic science. Many of the leading biotech inventors hold joint appointments as university faculty and industry consultants, embodying the dual institutional structure that defines life sciences innovation.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="geographic-distribution" data-section-label="Geographic Distribution"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Geographic Distribution</span><div class="flex-grow border-t border-border"></div></div><figure id="fig-biotech-by-country" aria-labelledby="fig-biotech-by-country-heading" aria-describedby="fig-biotech-by-country-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-by-country-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">The United States Leads in Biotech Patenting, With Significant Contributions From Japan, Germany, and Emerging Asian Economies</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Countries ranked by total biotechnology patents based on primary inventor location, showing the geographic distribution of biotech innovation.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Countries ranked by total biotechnology patents based on primary inventor location, showing the geographic distribution of biotech innovation.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: The United States Leads in Biotech Patenting, With Significant Contributions From Japan, Germany, and Emerging Asian Economies" style="height:900px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Countries ranked by total biotechnology-related patents based on primary inventor location. The United States maintains a substantial lead, reflecting its extensive network of research universities, NIH-funded research, and pharmaceutical industry concentration.</p></noscript></div><figcaption id="fig-biotech-by-country-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Countries ranked by total biotechnology-related patents based on primary inventor location. The United States maintains a substantial lead, reflecting its extensive network of research universities, NIH-funded research, and pharmaceutical industry concentration.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The geographic distribution of biotech patents reflects the importance of national research funding infrastructure, regulatory frameworks, and the concentration of pharmaceutical and life sciences firms.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The geographic distribution of biotechnology patents reveals the dominant role of the United States, which benefits from the world&#x27;s largest biomedical research funding apparatus through the National Institutes of Health, a dense network of research universities, and the concentration of major life sciences firms. Japan and Germany maintain strong positions reflecting their historical strengths in chemical and pharmaceutical engineering. The United Kingdom and France also rank prominently, ahead of China and South Korea, reflecting Europe&#x27;s deep life sciences research tradition. The growing presence of China and South Korea in biotech patenting signals the expansion of life sciences capabilities in East Asia, reflecting substantial government investment in genomics and biomanufacturing.</p></div></aside><figure id="fig-biotech-by-state" aria-labelledby="fig-biotech-by-state-heading" aria-describedby="fig-biotech-by-state-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-by-state-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotech Patenting Clusters in States With Major Research Universities and Pharmaceutical Industry Presence</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">US states ranked by total biotechnology patents based on primary inventor location, highlighting geographic clustering within the United States.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->US states ranked by total biotechnology patents based on primary inventor location, highlighting geographic clustering within the United States.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotech Patenting Clusters in States With Major Research Universities and Pharmaceutical Industry Presence" style="height:900px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->US states ranked by total biotechnology-related patents based on primary inventor location. The data reflect the co-location of research universities, NIH-funded medical centers, pharmaceutical companies, and venture capital that characterizes leading biotech hubs.</p></noscript></div><figcaption id="fig-biotech-by-state-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">US states ranked by total biotechnology-related patents based on primary inventor location. The data reflect the co-location of research universities, NIH-funded medical centers, pharmaceutical companies, and venture capital that characterizes leading biotech hubs.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The state-level distribution of biotech patents reveals distinct clusters reflecting the co-location of research universities, teaching hospitals, pharmaceutical firms, and venture capital -- the key ingredients of the biotech innovation ecosystem.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>Within the United States, biotechnology patenting clusters in states that combine leading research universities, NIH-funded medical centers, life sciences industry headquarters, and venture capital availability. California and Massachusetts are particularly prominent, reflecting the Bay Area biotech corridor and the Boston-Cambridge life sciences cluster. Iowa ranks sixth nationally, anchored by Pioneer Hi-Bred&#x27;s agricultural biotechnology headquarters, illustrating the significant role of crop science in biotech patenting. New Jersey benefits from its historical concentration of pharmaceutical and life sciences companies, while states such as Maryland and North Carolina have developed growing biotech ecosystems anchored by research triangle institutions and federal research facilities.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="quality-indicators" data-section-label="Quality Indicators"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Quality Indicators</span><div class="flex-grow border-t border-border"></div></div><figure id="fig-biotech-quality" aria-labelledby="fig-biotech-quality-heading" aria-describedby="fig-biotech-quality-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-quality-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotech Patent Quality Indicators Reveal Growing Complexity and Interdisciplinarity Over Time</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Average claims, backward citations, and technology scope (CPC subclasses) for biotechnology patents by year, measuring quality trends.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Average claims, backward citations, and technology scope (CPC subclasses) for biotechnology patents by year, measuring quality trends.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotech Patent Quality Indicators Reveal Growing Complexity and Interdisciplinarity Over Time" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Average claims, backward citations, and technology scope for biotechnology-related patents by year. The trends suggest that biotech patents have become more complex and interconnected, consistent with the expanding intersection of molecular biology with informatics, engineering, and clinical science.</p></noscript></div><figcaption id="fig-biotech-quality-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Average claims, backward citations, and technology scope for biotechnology-related patents by year. The trends suggest that biotech patents have become more complex and interconnected, consistent with the expanding intersection of molecular biology with informatics, engineering, and clinical science.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">Rising backward citations and technology scope suggest that biotech patents are becoming increasingly interconnected and interdisciplinary, reflecting the convergence of molecular biology with computational methods, materials science, and clinical applications.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>Biotechnology patents exhibit distinctive quality characteristics. The growing number of backward citations reflects the increasingly interconnected nature of life sciences research, where inventions build upon extensive prior art spanning molecular biology, biochemistry, pharmacology, and clinical medicine. The expanding technology scope indicates that biotech inventions increasingly span multiple CPC subclasses, consistent with the convergence of biological engineering with computational methods, materials science, and medical device technology. The trend in claim counts reflects evolving patent drafting strategies in the life sciences, where applicants must navigate complex patentability requirements for biological subject matter.</p></div></aside><figure id="fig-biotech-quality-bifurcation" aria-labelledby="fig-biotech-quality-bifurcation-heading" aria-describedby="fig-biotech-quality-bifurcation-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-quality-bifurcation-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotechnology Maintained Above-Average Top-Decile Citation Share Throughout Its History</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Share of biotech patents in the top decile of forward citations, by grant year.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Share of biotech patents in the top decile of forward citations, by grant year.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotechnology Maintained Above-Average Top-Decile Citation Share Throughout Its History" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Top-decile citation share measures the proportion of domain patents that rank in the top 10% of all patents by forward citations received.</p></noscript></div><figcaption id="fig-biotech-quality-bifurcation-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Top-decile citation share measures the proportion of domain patents that rank in the top 10% of all patents by forward citations received.</figcaption><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><div class="relative my-12 flex items-center scroll-mt-20" id="biotech-patenting-strategies" data-section-label="Biotech Patenting Strategies"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Biotech Patenting Strategies</span><div class="flex-grow border-t border-border"></div></div><section class="fade-in-section prose-custom my-8 max-w-prose text-lg leading-relaxed text-foreground/90 "><p>The leading biotechnology patent holders pursue distinct strategic approaches. Some organizations concentrate heavily on gene editing and modification technologies, while others maintain diversified portfolios spanning recombinant DNA, enzyme engineering, and nucleic acid detection. A comparison of subfield portfolios across major holders reveals the strategic choices that define each organization&#x27;s approach to biotech innovation and identifies subfields where competitive intensity is highest.</p></section><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The strategic portfolios of leading biotech patent holders reveal distinctive organizational approaches. Agricultural biotech firms concentrate heavily on genetic engineering categories, reflecting their focus on crop trait engineering. Research universities often hold stronger positions in gene editing and fundamental genetic engineering methods, reflecting their role as originators of basic scientific breakthroughs. Specialized biotechnology firms frequently focus on narrow but high-value niches such as enzyme engineering or nucleic acid detection platforms. The diversity of strategic approaches across organizations underscores the breadth of the biotechnology field and the multiple pathways through which inventive effort can create commercial value.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="biotech-as-a-platform-technology" data-section-label="Biotech as a Platform Technology"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Biotech as a Platform Technology</span><div class="flex-grow border-t border-border"></div></div><section class="fade-in-section prose-custom my-8 max-w-prose text-lg leading-relaxed text-foreground/90 "><p>A defining characteristic of platform technologies is their diffusion into multiple sectors of the economy. By tracking how frequently biotechnology-classified patents also carry CPC codes from non-biotech technology areas, it is possible to measure the spread of biotech methods into healthcare delivery, agriculture, industrial chemistry, and other domains. The breadth of this diffusion provides evidence for biotechnology&#x27;s role as a foundational technology with applications far beyond its immediate field.</p></section><figure id="fig-biotech-diffusion" aria-labelledby="fig-biotech-diffusion-heading" aria-describedby="fig-biotech-diffusion-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-diffusion-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotechnology Patents Show Increasing Co-Classification With Healthcare, Physics, and Agricultural CPC Codes</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Percentage of biotech patents co-classified with non-biotech CPC sections, measuring biotechnology&#x27;s diffusion into healthcare, agriculture, and industry.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Percentage of biotech patents co-classified with non-biotech CPC sections, measuring biotechnology&#x27;s diffusion into healthcare, agriculture, and industry.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotechnology Patents Show Increasing Co-Classification With Healthcare, Physics, and Agricultural CPC Codes" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Percentage of biotechnology patents that also carry CPC codes from each non-biotech CPC section. Rising lines indicate biotech methods diffusing into that sector. The most prominent pattern is the strong and growing co-occurrence with Human Necessities (Section A, encompassing healthcare and agriculture) and Physics (Section G, encompassing measurement and testing technologies).</p></noscript></div><figcaption id="fig-biotech-diffusion-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Percentage of biotechnology patents that also carry CPC codes from each non-biotech CPC section. Rising lines indicate biotech methods diffusing into that sector. The most prominent pattern is the strong and growing co-occurrence with Human Necessities (Section A, encompassing healthcare and agriculture) and Physics (Section G, encompassing measurement and testing technologies).</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The co-classification of biotech patents with healthcare (Section A) and physics (Section G) CPC codes reflects the fundamental role of molecular biology in drug development, agriculture, diagnostics, and measurement technologies. The growing co-occurrence with other sections suggests expanding applications of biotech methods across the economy.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>Biotechnology exhibits the characteristics of a platform technology with broad applicability across the economy. The strong co-classification with Human Necessities (Section A) reflects biotech&#x27;s deep connections to healthcare, pharmaceuticals, and agriculture -- the sectors where genetic engineering has had its most significant impact. The substantial co-occurrence with Physics (Section G, encompassing measurement and testing technologies) reflects the importance of analytical and diagnostic instrumentation in the field, while growing connections to other sections suggest that biotech methods are increasingly being applied to industrial processes, materials science, and environmental remediation. This cross-domain diffusion pattern supports the characterization of biotechnology as a general-purpose technology whose influence extends well beyond the life sciences.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="the-collaborative-structure-of-biotech-innovation" data-section-label="The Collaborative Structure of Biotech Innovation"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">The Collaborative Structure of Biotech Innovation</span><div class="flex-grow border-t border-border"></div></div><section class="fade-in-section prose-custom my-8 max-w-prose text-lg leading-relaxed text-foreground/90 "><p>Biotechnology patents increasingly involve larger inventor teams, reflecting the multidisciplinary nature of modern life sciences research. Comparing team sizes between biotech and non-biotech patents reveals how the collaborative demands of genetic engineering, clinical trials, and regulatory compliance shape the structure of inventive activity in the life sciences.</p></section><figure id="fig-biotech-team-comparison" aria-labelledby="fig-biotech-team-comparison-heading" aria-describedby="fig-biotech-team-comparison-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-team-comparison-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotech Patents Consistently Involve Larger Teams Than Non-Biotech Patents, Reflecting the Multidisciplinary Demands of Life Sciences</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Average inventors per patent for biotech versus non-biotech utility patents by year, showing the widening collaboration gap.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Average inventors per patent for biotech versus non-biotech utility patents by year, showing the widening collaboration gap.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotech Patents Consistently Involve Larger Teams Than Non-Biotech Patents, Reflecting the Multidisciplinary Demands of Life Sciences" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Average number of inventors per patent for biotechnology-related versus non-biotech utility patents, 1976-2025. The data indicate that biotech patents have consistently involved larger teams, and the gap has widened as the complexity of genetic engineering, genomics, and clinical development has increased.</p></noscript></div><figcaption id="fig-biotech-team-comparison-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Average number of inventors per patent for biotechnology-related versus non-biotech utility patents, 1976-2025. The data indicate that biotech patents have consistently involved larger teams, and the gap has widened as the complexity of genetic engineering, genomics, and clinical development has increased.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">Biotech patents consistently involve larger teams than non-biotech patents, and the gap has widened over time. This pattern reflects the inherent multidisciplinarity of life sciences innovation, which requires collaboration across molecular biology, chemistry, clinical medicine, and increasingly computational science.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><figure id="fig-biotech-assignee-type" aria-labelledby="fig-biotech-assignee-type-heading" aria-describedby="fig-biotech-assignee-type-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-assignee-type-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Corporate Assignees Dominate Aggregate Biotech Patent Counts, Though Individual Universities Rank Highly</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Distribution of biotech patents by assignee type (corporate, university, government, individual) over time, revealing the distinctive institutional mix.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Distribution of biotech patents by assignee type (corporate, university, government, individual) over time, revealing the distinctive institutional mix.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Corporate Assignees Dominate Aggregate Biotech Patent Counts, Though Individual Universities Rank Highly" style="height:500px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Distribution of biotechnology patent assignees by type (corporate, university, government, individual) over time. Corporate assignees account for 96-98% of biotech patents in the aggregate categorization. While individual universities such as the University of California (#1 overall), Harvard (#8), and Stanford (#10) rank among the top assignees, the aggregate &quot;University/Other&quot; category remains small, suggesting many university-originated patents may be assigned to corporate licensees.</p></noscript></div><figcaption id="fig-biotech-assignee-type-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Distribution of biotechnology patent assignees by type (corporate, university, government, individual) over time. Corporate assignees account for 96-98% of biotech patents in the aggregate categorization. While individual universities such as the University of California (#1 overall), Harvard (#8), and Stanford (#10) rank among the top assignees, the aggregate &quot;University/Other&quot; category remains small, suggesting many university-originated patents may be assigned to corporate licensees.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The assignee type distribution reveals an apparent paradox: while individual universities rank among the top biotech patent holders, the aggregate University/Other category accounts for less than 1% of patents. This disconnect likely reflects the practice of assigning university-originated inventions to corporate licensees and spin-off companies.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The distribution of biotechnology patents by assignee type reveals an instructive disconnect. Corporate assignees account for 96-98% of biotech patents in the aggregate data, yet individual universities rank among the very top assignees -- the University of California holds the most biotech patents of any organization, and Harvard and Stanford both appear in the top ten. This apparent paradox likely reflects the common practice whereby university-originated inventions are assigned to corporate licensees, spin-off companies, or joint ventures, causing them to appear as corporate patents in aggregate categorizations. The Bayh-Dole Act&#x27;s impact on academic patenting may thus be understated by aggregate assignee type data, as many commercially significant biotech inventions originate in university laboratories but are ultimately held by corporate entities.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="ethical-and-regulatory-considerations" data-section-label="Ethical and Regulatory Considerations"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Ethical and Regulatory Considerations</span><div class="flex-grow border-t border-border"></div></div><section class="fade-in-section prose-custom my-8 max-w-prose text-lg leading-relaxed text-foreground/90 "><p>Biotechnology and gene editing patents occupy a unique position at the intersection of innovation policy, bioethics, and public health regulation. The Supreme Court&#x27;s decision in Association for Molecular Pathology v. Myriad Genetics (2013) established that naturally occurring DNA sequences cannot be patented, while synthetic cDNA remains patentable -- a distinction that continues to shape patent strategy in genomics. The ongoing CRISPR patent dispute between the Broad Institute and the University of California illustrates how foundational biotech patents can become the subject of protracted legal battles with billions of dollars in commercial value at stake.</p><p>Gene editing technologies raise particularly acute ethical questions. The ability to modify human germline cells -- changes that would be inherited by future generations -- has prompted international calls for moratoriums and regulatory frameworks that have no parallel in other technology domains. These ethical and regulatory dimensions create unique constraints on how biotech patents translate into products and therapies, distinguishing the field from domains such as artificial intelligence or semiconductors where the path from patent to market is less encumbered by ethical oversight.</p></section><aside aria-label="Key insight" class="fade-in-section my-8 flex gap-3 rounded-lg border border-amber-500/30 bg-amber-50/50 p-4 dark:bg-amber-950/20 "><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-lightbulb mt-0.5 h-5 w-5 shrink-0 text-amber-500" aria-hidden="true"><path d="M15 14c.2-1 .7-1.7 1.5-2.5 1-.9 1.5-2.2 1.5-3.5A6 6 0 0 0 6 8c0 1 .2 2.2 1.5 3.5.7.7 1.3 1.5 1.5 2.5"></path><path d="M9 18h6"></path><path d="M10 22h4"></path></svg><div class="text-sm leading-relaxed text-foreground/90"><p>The ethical and regulatory landscape surrounding biotechnology patents creates both constraints and incentives that shape inventive activity in distinctive ways. Patent exclusivity provides the economic incentive necessary to justify the substantial investment required for drug development and clinical trials -- a process that typically costs over a billion dollars and spans more than a decade. At the same time, the patentability of biological materials remains subject to evolving legal standards and ethical considerations that have no direct analogue in other technology domains. The tension between incentivizing innovation and ensuring equitable access to life-saving technologies -- exemplified by debates over mRNA vaccine patents during the COVID-19 pandemic -- remains one of the most consequential policy questions in the modern patent system.</p></div></aside><div class="relative my-12 flex items-center scroll-mt-20" id="analytical-deep-dives" data-section-label="Analytical Deep Dives"><div class="flex-grow border-t border-border"></div><span class="mx-4 text-xs font-medium uppercase tracking-widest text-muted-foreground">Analytical Deep Dives</span><div class="flex-grow border-t border-border"></div></div><p class="text-sm text-muted-foreground mt-4">For metric definitions and cross-domain comparisons, see the <a class="underline decoration-muted-foreground/50 hover:decoration-foreground transition-colors" href="/patentworld/chapters/deep-dive-overview/">ACT 6 Overview</a>.</p><figure id="fig-biotech-cr4" aria-labelledby="fig-biotech-cr4-heading" aria-describedby="fig-biotech-cr4-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-cr4-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Top-4 Concentration in Biotechnology Patents Peaked at 13.5% in 2007 Before Declining to 4.6% by 2025</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Share of annual domain patents held by the four largest organizations, measuring organizational concentration in biotechnology patenting.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Share of annual domain patents held by the four largest organizations, measuring organizational concentration in biotechnology patenting.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Top-4 Concentration in Biotechnology Patents Peaked at 13.5% in 2007 Before Declining to 4.6% by 2025" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->CR4 computed as the sum of the top 4 organizations&#x27; annual patent counts divided by total domain patents. Biotechnology exhibits the lowest peak concentration among ACT 6 domains, reflecting the highly distributed nature of life sciences research across universities, startups, and pharmaceutical firms.</p></noscript></div><figcaption id="fig-biotech-cr4-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">CR4 computed as the sum of the top 4 organizations&#x27; annual patent counts divided by total domain patents. Biotechnology exhibits the lowest peak concentration among ACT 6 domains, reflecting the highly distributed nature of life sciences research across universities, startups, and pharmaceutical firms.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The low and declining concentration is consistent with the Bayh-Dole Act&#x27;s legacy of distributed university patenting and the biotech sector&#x27;s reliance on specialized startups rather than large vertically integrated firms.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><figure id="fig-biotech-entropy" aria-labelledby="fig-biotech-entropy-heading" aria-describedby="fig-biotech-entropy-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-entropy-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotechnology Subfield Diversity Tripled From 0.32 in 1976 to 0.94 by 2025, Reflecting the Field&#x27;s Maturation</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Normalized Shannon entropy of subfield patent distributions, measuring how evenly inventive activity is spread across biotechnology subfields.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Normalized Shannon entropy of subfield patent distributions, measuring how evenly inventive activity is spread across biotechnology subfields.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotechnology Subfield Diversity Tripled From 0.32 in 1976 to 0.94 by 2025, Reflecting the Field&#x27;s Maturation" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Normalized Shannon entropy increased from 0.32 (dominated by recombinant DNA) to 0.94 (broadly distributed across gene editing, expression vectors, cell engineering, and diagnostics). This trajectory reflects the successive waves of innovation from recombinant DNA to PCR to CRISPR.</p></noscript></div><figcaption id="fig-biotech-entropy-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Normalized Shannon entropy increased from 0.32 (dominated by recombinant DNA) to 0.94 (broadly distributed across gene editing, expression vectors, cell engineering, and diagnostics). This trajectory reflects the successive waves of innovation from recombinant DNA to PCR to CRISPR.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The biotechnology diversification trajectory parallels AI&#x27;s but is shaped by different mechanisms: successive breakthrough technologies (PCR, monoclonal antibodies, CRISPR) each opened new subfields, progressively balancing the distribution of inventive activity.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><figure id="fig-biotech-velocity" aria-labelledby="fig-biotech-velocity-heading" aria-describedby="fig-biotech-velocity-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-velocity-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Later Biotech Entrants Patent at Modestly Higher Velocity: 2000s Cohort Averages 26.9 Patents per Year Versus 19.2 for 1970s Entrants</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Mean patents per active year for top organizations grouped by the decade in which they first filed a biotechnology patent.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Mean patents per active year for top organizations grouped by the decade in which they first filed a biotechnology patent.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Later Biotech Entrants Patent at Modestly Higher Velocity: 2000s Cohort Averages 26.9 Patents per Year Versus 19.2 for 1970s Entrants" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Mean patents per active year for top biotech organizations grouped by entry decade. The 1.4x increase is the smallest among mature ACT 6 domains, suggesting that biotechnology patenting has not become substantially easier over time, consistent with the domain&#x27;s high regulatory and scientific barriers.</p></noscript></div><figcaption id="fig-biotech-velocity-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Mean patents per active year for top biotech organizations grouped by entry decade. The 1.4x increase is the smallest among mature ACT 6 domains, suggesting that biotechnology patenting has not become substantially easier over time, consistent with the domain&#x27;s high regulatory and scientific barriers.</figcaption><div class="mt-2 border-l-2 border-primary/30 pl-4 text-sm leading-relaxed text-foreground/80">The modest velocity increase contrasts with AI&#x27;s 2.0x and green innovation&#x27;s 5.5x ratios, reflecting the persistent barriers to biotech patenting imposed by regulatory requirements, clinical validation timelines, and the fundamental complexity of biological systems.</div><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><figure id="fig-biotech-filing-vs-grant" aria-labelledby="fig-biotech-filing-vs-grant-heading" aria-describedby="fig-biotech-filing-vs-grant-caption" class="fade-in-section relative my-16 rounded-lg border bg-card p-4 sm:p-6 overflow-hidden max-w-[960px] mx-auto  "><div class="absolute top-0 left-0 right-0 h-[2px]" style="background:linear-gradient(90deg, hsl(var(--chart-1)), hsl(var(--chart-5)))" aria-hidden="true"></div><h3 id="fig-biotech-filing-vs-grant-heading" class="mb-1 font-sans text-base font-bold leading-snug tracking-tight text-foreground/90">Biotech Filings Peaked at 4,763 in 2018 While Grants Reached 4,360 in 2020 — Reflecting Lengthy Examination Times</h3><p class="mb-4 text-[13px] leading-relaxed text-muted-foreground">Annual patent filings versus grants for biotechnology, showing the filing-to-grant pipeline.</p><noscript><p class="my-4 rounded border border-muted p-4 text-sm text-muted-foreground">This visualization requires JavaScript.<!-- --> <!-- -->Annual patent filings versus grants for biotechnology, showing the filing-to-grant pipeline.</p></noscript><div class="chart-container-inner relative flex items-end justify-center overflow-hidden" role="img" aria-label="Loading chart: Biotech Filings Peaked at 4,763 in 2018 While Grants Reached 4,360 in 2020 — Reflecting Lengthy Examination Times" style="height:600px;min-height:250px"><div class="absolute inset-0 flex items-end px-12 pb-10 pt-8" aria-hidden="true"><div class="absolute left-10 top-6 bottom-8 w-px bg-muted-foreground/15"></div><div class="absolute left-10 right-6 bottom-8 h-px bg-muted-foreground/15"></div><div class="flex items-end gap-[3%] w-full h-full"><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:35%;animation-delay:0ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:45%;animation-delay:80ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:50%;animation-delay:160ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:60%;animation-delay:240ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:72%;animation-delay:320ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:68%;animation-delay:400ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:80%;animation-delay:480ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:75%;animation-delay:560ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:65%;animation-delay:640ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:55%;animation-delay:720ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:40%;animation-delay:800ms"></div><div class="flex-1 rounded-t bg-muted/60 animate-pulse" style="height:30%;animation-delay:880ms"></div></div></div><p class="relative z-10 mb-4 text-xs text-muted-foreground/50">Loading visualization…</p><noscript><p class="absolute inset-0 flex items-center justify-center text-sm text-muted-foreground px-8 text-center">This interactive chart requires JavaScript. <!-- -->Biotechnology patents exhibit a moderate filing-to-grant lag. Filings peaked in 2018 and have since declined, while grants peaked in 2020. The relatively stable grant output despite declining filings reflects the deep pipeline of biotech applications undergoing examination.</p></noscript></div><figcaption id="fig-biotech-filing-vs-grant-caption" class="mt-2 text-[13px] leading-relaxed text-muted-foreground/80">Biotechnology patents exhibit a moderate filing-to-grant lag. Filings peaked in 2018 and have since declined, while grants peaked in 2020. The relatively stable grant output despite declining filings reflects the deep pipeline of biotech applications undergoing examination.</figcaption><div class="mt-3 pt-3 border-t border-border/40"><button class="block text-xs text-muted-foreground/60 hover:text-muted-foreground transition-colors cursor-pointer" aria-expanded="false">Cite this figure</button></div></figure><aside aria-label="Chapter recap" class="fade-in-section my-8 rounded-lg border-l-4 border-emerald-500 bg-emerald-50/50 p-5 dark:bg-emerald-950/20 "><h3 class="mb-3 text-sm font-semibold uppercase tracking-wide text-emerald-700 dark:text-emerald-400">Chapter Recap</h3><div class="mb-4"><h4 class="mb-2 flex items-center gap-1.5 text-xs font-medium uppercase tracking-wide text-muted-foreground"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-circle-check h-3.5 w-3.5" aria-hidden="true"><circle cx="12" cy="12" r="10"></circle><path d="m9 12 2 2 4-4"></path></svg>Key Takeaways</h4><ul class="space-y-1.5 pl-5 text-sm leading-relaxed text-foreground/90"><li class="list-disc">Biotechnology achieved the lowest top-four concentration (4.6% by 2025) among all advanced technology domains, reflecting exceptionally broad-based participation.</li><li class="list-disc">Subfield diversity tripled from 0.32 in 1976 to 0.94 by 2025, reflecting successive waves from recombinant DNA to CRISPR-Cas9.</li></ul></div><div class="mb-4"><h4 class="mb-2 flex items-center gap-1.5 text-xs font-medium uppercase tracking-wide text-muted-foreground"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-flask-conical h-3.5 w-3.5" aria-hidden="true"><path d="M14 2v6a2 2 0 0 0 .245.96l5.51 10.08A2 2 0 0 1 18 22H6a2 2 0 0 1-1.755-2.96l5.51-10.08A2 2 0 0 0 10 8V2"></path><path d="M6.453 15h11.094"></path><path d="M8.5 2h7"></path></svg>What Would Challenge the Findings</h4><p class="pl-5 text-sm leading-relaxed text-foreground/80">If CRISPR drove the latest diversity wave, then gene-editing subclass patents should show discontinuous growth after the 2012 Doudna-Charpentier publication.</p></div><div><h4 class="mb-2 flex items-center gap-1.5 text-xs font-medium uppercase tracking-wide text-muted-foreground"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-arrow-right h-3.5 w-3.5" aria-hidden="true"><path d="M5 12h14"></path><path d="m12 5 7 7-7 7"></path></svg>Next Analysis</h4><a class="group ml-5 flex items-center gap-2 text-sm text-emerald-700 underline decoration-emerald-500/30 hover:decoration-emerald-500 dark:text-emerald-400" href="/patentworld/chapters/blockchain/"><span><strong>Blockchain</strong>: <!-- -->Distributed trust in the digital economy — the only technology domain to reverse course</span></a></div></aside><div class="my-6 flex gap-3 rounded-md border bg-muted/50 p-4 text-sm text-muted-foreground"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-info mt-0.5 h-4 w-4 shrink-0" aria-hidden="true"><circle cx="12" cy="12" r="10"></circle><path d="M12 16v-4"></path><path d="M12 8h.01"></path></svg><div>Biotechnology patents are identified using specific CPC groups within genetic engineering and molecular biology: C12N15 (mutation or genetic engineering), C12N9 (enzymes and proenzymes), and C12Q1/68 (nucleic acid detection). These targeted codes capture core molecular biotechnology while excluding broader C12N and C12Q categories that include conventional microbiology. Subfield classifications distinguish gene editing and modification, expression vectors, recombinant DNA, enzyme engineering, nucleic acid detection, and other genetic engineering categories. A patent is classified as biotechnology-related if any of its CPC codes fall within these categories. Geographic attribution is based on the primary inventor&#x27;s location. Strategy data show patent counts per biotech sub-area for the top assignees. Diffusion analysis measures co-occurrence of biotech CPC codes with non-biotech CPC sections. Source: PatentsView / USPTO.</div></div><nav aria-label="Chapter navigation" class="mt-16 flex items-stretch gap-4"><a class="flex flex-1 items-center gap-3 rounded-lg border p-4 hover:bg-accent transition-colors focus:outline-none focus:ring-2 focus:ring-primary" href="/patentworld/chapters/autonomous-vehicles/"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-left h-5 w-5 shrink-0 text-muted-foreground" aria-hidden="true"><path d="m15 18-6-6 6-6"></path></svg><div class="text-right flex-1"><div class="text-xs text-muted-foreground">Previous</div><div class="text-sm font-medium">Autonomous Vehicles &amp; ADAS</div></div></a><a class="flex flex-1 items-center gap-3 rounded-lg border p-4 hover:bg-accent transition-colors focus:outline-none focus:ring-2 focus:ring-primary" href="/patentworld/chapters/blockchain/"><div class="flex-1"><div class="text-xs text-muted-foreground">Next</div><div class="text-sm font-medium">Blockchain &amp; Decentralized Systems</div></div><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-chevron-right h-5 w-5 shrink-0 text-muted-foreground" aria-hidden="true"><path d="m9 18 6-6-6-6"></path></svg></a></nav></div></article><p class="mt-12 border-t pt-4 text-xs text-muted-foreground">Data coverage: January 1976 through September 2025. All 2025 figures reflect partial-year data.</p></div></div></div></main><footer class="border-t mt-20"><div class="mx-auto max-w-7xl px-4 py-8 lg:px-8"><div class="flex flex-col items-center justify-between gap-4 sm:flex-row"><p class="text-sm text-muted-foreground">Data from<!-- --> <a href="https://patentsview.org" target="_blank" rel="noopener noreferrer" class="underline hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm">PatentsView</a> <!-- -->(USPTO), accessed Feb 2026. Coverage: 1976–Sep 2025.</p><div class="flex items-center gap-4 text-sm text-muted-foreground"><a class="hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm" href="/patentworld/methodology/">Methodology</a><a class="hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm" href="/patentworld/about/">About</a><a class="hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm" href="/patentworld/explore/">Explore</a><a class="hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm" href="/patentworld/about/#faq">FAQ</a></div></div><p class="text-xs text-muted-foreground/70">© <!-- -->2026<!-- --> Saerom (Ronnie) Lee. Content licensed under<!-- --> <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank" rel="noopener noreferrer" class="underline hover:text-foreground">CC BY 4.0</a>.</p></div></footer><script src="/patentworld/_next/static/chunks/webpack-9ee10b824e272683.js" async=""></script><script>(self.__next_f=self.__next_f||[]).push([0]);self.__next_f.push([2,null])</script><script>self.__next_f.push([1,"1:HL[\"/patentworld/_next/static/media/636a5ac981f94f8b-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n2:HL[\"/patentworld/_next/static/media/bb3ef058b751a6ad-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n3:HL[\"/patentworld/_next/static/media/eaead17c7dbfcd5d-s.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"type\":\"font/woff2\"}]\n4:HL[\"/patentworld/_next/static/css/68682e2a9cafe58c.css\",\"style\"]\n"])</script><script>self.__next_f.push([1,"5:I[12846,[],\"\"]\n7:I[19107,[],\"ClientPageRoot\"]\n8:I[75520,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"917\",\"static/chunks/917-12c25c540c11b06a.js\",\"553\",\"static/chunks/553-1b17ddc1eb6d1252.js\",\"1530\",\"static/chunks/1530-682cb64901734b8c.js\",\"5736\",\"static/chunks/5736-874586b50ac068d0.js\",\"894\",\"static/chunks/894-c5aad0a13cab70b7.js\",\"6498\",\"static/chunks/6498-c76f40af77abdc9f.js\",\"3796\",\"static/chunks/3796-443ac1f8abcede52.js\",\"2598\",\"static/chunks/2598-670b146a3686bad7.js\",\"1203\",\"static/chunks/app/chapters/biotechnology/page-f74bc9d83f064314.js\"],\"default\",1]\na:I[4707,[],\"\"]\nb:I[36423,[],\"\"]\nc:I[23231,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static/chunks/5947-0bb5c0eb14de0f0e.js\",\"3544\",\"static/chunks/app/chapters/layout-ef7450d546bbb756.js\"],\"ChapterSidebar\"]\nd:I[80482,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static/chunks/5947-0bb5c0eb14de0f0e.js\",\"3544\",\"static/chunks/app/chapters/layout-ef7450d546bbb756.js\"],\"Breadcrumb\"]\ne:I[50435,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static/chunks/5947-0bb5c0eb14de0f0e.js\",\"3544\",\"static/chunks/app/chapters/layout-ef7450d546bbb756.js\"],\"ChapterTableOfContents\"]\nf:I[80532,[\"1054\",\"static/chunks/app/chapters/error-adaa9b1cf3e1bbaf.js\"],\"default\"]\n11:I[25922,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static/chunks/5947-0bb5c0eb14de0f0e.js\",\"3185\",\"static/chunks/app/layout-fef62e2bdb216f51.js\"],\"ThemeProvider\"]\n12:I[45367,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static/chunks/5947-0bb5c0eb14de0f0e.js\",\"3185\",\"static/chunks/app/layout-fef62e2bdb216f51.js\"],\"ReadingProgress\"]\n13:I[29742,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static/chunks/5947-0bb5c0eb14de0f0e.js\",\"3185\",\"static/chunks/app/layout-fef62e2bdb216f51.js\"],\"Header\"]\n14:I[38212,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static/chunks/5947-0bb5c0eb14de0f0e.js\",\"3185\",\"static/chunks/app/layout-fef62e2bdb216f51.js\"],\"BackToTop\"]\n15:I[72972,[\"2972\",\"static/chunks/2972-6578f2e3e7dda066.js\",\"5947\",\"static"])</script><script>self.__next_f.push([1,"/chunks/5947-0bb5c0eb14de0f0e.js\",\"3185\",\"static/chunks/app/layout-fef62e2bdb216f51.js\"],\"\"]\n17:I[61060,[],\"\"]\n9:T62d,[{\"@context\":\"https://schema.org\",\"@type\":\"ScholarlyArticle\",\"headline\":\"Biotech Patents Transformed by Gene Editing\",\"description\":\"Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation.\",\"author\":{\"@type\":\"Person\",\"name\":\"Saerom (Ronnie) Lee\",\"jobTitle\":\"Assistant Professor of Management\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"The Wharton School, University of Pennsylvania\"}},\"publisher\":{\"@type\":\"Organization\",\"name\":\"University of Pennsylvania\",\"url\":\"https://www.upenn.edu\"},\"datePublished\":\"2025-01-01\",\"dateModified\":\"2026-02-14\",\"mainEntityOfPage\":\"https://patentworld.vercel.app/chapters/biotechnology/\",\"image\":\"https://patentworld.vercel.app/og/home.png\",\"keywords\":\"biotech patents, gene editing patents, CRISPR patents, recombinant DNA, enzyme engineering, nucleic acid detection\",\"isPartOf\":{\"@type\":\"WebSite\",\"name\":\"PatentWorld\",\"url\":\"https://patentworld.vercel.app\"},\"about\":{\"@type\":\"Dataset\",\"name\":\"US Patent Data (1976-2025)\",\"description\":\"Analysis of 9.36 million US utility patents from PatentsView / USPTO.\",\"temporalCoverage\":\"1976/2025\"}},{\"@context\":\"https://schema.org\",\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://patentworld.vercel.app\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Act 6: Deep Dives\",\"item\":\"https://patentworld.vercel.app/#acts\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Biotechnology \u0026 Gene Editing\",\"item\":\"https://patentworld.vercel.app/chapters/biotechnology/\"}]}]10:T39d6,"])</script><script>self.__next_f.push([1,"[{\"@context\":\"https://schema.org\",\"@type\":\"WebSite\",\"name\":\"PatentWorld\",\"description\":\"Interactive exploration of 9.36 million US patents granted by the USPTO from 1976 to 2025.\",\"url\":\"https://patentworld.vercel.app\",\"author\":{\"@type\":\"Person\",\"name\":\"Saerom (Ronnie) Lee\",\"jobTitle\":\"Assistant Professor of Management\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"The Wharton School, University of Pennsylvania\"},\"url\":\"https://www.saeromlee.com\"},\"about\":{\"@type\":\"Dataset\",\"name\":\"US Patent Data (1976-2025)\",\"description\":\"Analysis of 9.36 million US patents from PatentsView, covering technology classifications, inventor demographics, geographic distribution, citation networks, and patent quality indicators.\",\"creator\":{\"@type\":\"Organization\",\"name\":\"USPTO / PatentsView\"},\"temporalCoverage\":\"1976/2025\",\"spatialCoverage\":\"United States\",\"variableMeasured\":[\"Patent grants per year\",\"Technology classifications (CPC)\",\"Inventor demographics and collaboration\",\"Geographic distribution\",\"Citation networks and patent quality\"]},\"hasPart\":[{\"@type\":\"ScholarlyArticle\",\"name\":\"Patent Count\",\"description\":\"Annual US patent grants (all types) increased more than five-fold from approximately 70,000 in 1976 to 374,000 in 2024, peaking at 393,000 (all types) in 2019. Average (mean) grant pendency peaked at 3.8 years in 2010 before moderating.\",\"url\":\"https://patentworld.vercel.app/chapters/system-patent-count/\",\"position\":1},{\"@type\":\"ScholarlyArticle\",\"name\":\"Patent Quality\",\"description\":\"Average claims per patent doubled from 9.4 to a peak of 18.9 in 2005. Forward citations rose to a peak of 6.4 in 2019. System-wide originality rose from 0.09 to 0.25 (section-level averages reached 0.45-0.55 by the 2020s) while generality fell from 0.28 to 0.15.\",\"url\":\"https://patentworld.vercel.app/chapters/system-patent-quality/\",\"position\":2},{\"@type\":\"ScholarlyArticle\",\"name\":\"Patent Fields\",\"description\":\"CPC sections G and H gained 30 percentage points of share over five decades, rising from 27% to 57% of all grants. The fastest digital technology classes grew by more than 1,000%. Patent grant concentration by assignee remains below conventional thresholds across CPC sections.\",\"url\":\"https://patentworld.vercel.app/chapters/system-patent-fields/\",\"position\":3},{\"@type\":\"ScholarlyArticle\",\"name\":\"Convergence\",\"description\":\"Multi-section patents rose from 21% to 40% of all grants by 2024. The G-H convergence pair rose from 12.5% to 37.5% of cross-section patents between 1976-1995 and 2011-2025.\",\"url\":\"https://patentworld.vercel.app/chapters/system-convergence/\",\"position\":4},{\"@type\":\"ScholarlyArticle\",\"name\":\"The Language of Innovation\",\"description\":\"Computing and semiconductor topics grew from 12% to 33% of all patents since 1976. Patent novelty (median entropy) rose 6.6% from 1.97 to 2.10, with an upward trend since the late 1980s.\",\"url\":\"https://patentworld.vercel.app/chapters/system-language/\",\"position\":5},{\"@type\":\"ScholarlyArticle\",\"name\":\"Patent Law \u0026 Policy\",\"description\":\"The Alice decision (2014) curtailed software patent eligibility, while the AIA (2011) was the most significant reform since 1952. Twenty-one legislative and judicial events from 1980 to 2025 are associated with observable shifts in filing patterns within one to two years.\",\"url\":\"https://patentworld.vercel.app/chapters/system-patent-law/\",\"position\":6},{\"@type\":\"ScholarlyArticle\",\"name\":\"Public Investment\",\"description\":\"Government-funded patents rose from 1,294 in 1980 to 8,359 in 2019 after the Bayh-Dole Act. HHS/NIH leads with 55,587 patents, followed by Defense (43,736) and Energy (33,994).\",\"url\":\"https://patentworld.vercel.app/chapters/system-public-investment/\",\"position\":7},{\"@type\":\"ScholarlyArticle\",\"name\":\"Assignee Composition\",\"description\":\"Corporate assignees grew from 94% to 99% of US patent grants. Foreign assignees surpassed US-based assignees around 2007. Japan accounts for 1.45 million US patents since 1976.\",\"url\":\"https://patentworld.vercel.app/chapters/org-composition/\",\"position\":8},{\"@type\":\"ScholarlyArticle\",\"name\":\"Organizational Patent Count\",\"description\":\"IBM leads with 161,888 cumulative grants. Samsung peaked at 9,716 annual grants in 2024. The top 100 organizations hold 32-39% of corporate patents.\",\"url\":\"https://patentworld.vercel.app/chapters/org-patent-count/\",\"position\":9},{\"@type\":\"ScholarlyArticle\",\"name\":\"Organizational Patent Quality\",\"description\":\"Amazon holds the highest blockbuster rate at 6.7%. Microsoft leads in average citations at 30.7. Citation half-lives range from 6.3 years (Huawei) to 14.3 years.\",\"url\":\"https://patentworld.vercel.app/chapters/org-patent-quality/\",\"position\":10},{\"@type\":\"ScholarlyArticle\",\"name\":\"Patent Portfolio\",\"description\":\"50 companies (248 company-decade observations) cluster into 8 industry groups by patent portfolio similarity. Portfolio diversity rose across leading firms, with Mitsubishi Electric reaching a peak Shannon entropy of 7.1 across 287 CPC subclasses. 51 technology pivots detected across 20 companies, which can precede strategic shifts that later become publicly visible.\",\"url\":\"https://patentworld.vercel.app/chapters/org-patent-portfolio/\",\"position\":11},{\"@type\":\"ScholarlyArticle\",\"name\":\"Interactive Company Profiles\",\"description\":\"Interactive dashboards for each organization across five analytical dimensions: output trajectories, technology portfolios, citation quality, innovation strategy radar, and grant lag trends. Search and compare any assignee in the dataset.\",\"url\":\"https://patentworld.vercel.app/chapters/org-company-profiles/\",\"position\":12},{\"@type\":\"ScholarlyArticle\",\"name\":\"Top Inventors\",\"description\":\"The top 5% of inventors (by cumulative output) account for 63.2% of all patents. Their annual share rose from 26% to 60% between 1976 and 2025. The most prolific inventor holds 6,709 patents. Citation impact ranges from 10 to 965 average citations among top 100.\",\"url\":\"https://patentworld.vercel.app/chapters/inv-top-inventors/\",\"position\":13},{\"@type\":\"ScholarlyArticle\",\"name\":\"Generalist vs. Specialist\",\"description\":\"Specialist inventors rose from 20% to 48% of the inventor workforce. Generalists earn 9.3 forward citations per patent vs. 8.2 for specialists and score 0.212 on originality vs. 0.165.\",\"url\":\"https://patentworld.vercel.app/chapters/inv-generalist-specialist/\",\"position\":14},{\"@type\":\"ScholarlyArticle\",\"name\":\"Serial Inventors vs. New Entrants\",\"description\":\"Annual first-time inventor entries peaked at 140,490 in 2019. Only 37-51% of inventors survive past five career years. Productivity rises from 1.4 to 2.1 patents per year.\",\"url\":\"https://patentworld.vercel.app/chapters/inv-serial-new/\",\"position\":15},{\"@type\":\"ScholarlyArticle\",\"name\":\"Gender and Patenting\",\"description\":\"Female inventor share rose from 2.8% in 1976 to 14.9% in 2025 (through September). All-male teams average 14.2 forward citations, mixed-gender teams 12.6, and all-female teams 9.5. Chemistry leads cumulative female representation at 14.6% (1976-2025), reaching 23.4% in the most recent period.\",\"url\":\"https://patentworld.vercel.app/chapters/inv-gender/\",\"position\":16},{\"@type\":\"ScholarlyArticle\",\"name\":\"Team Size and Collaboration\",\"description\":\"Average patent team size increased from 1.7 to 3.2 inventors, while the solo-inventor share fell from 58% to 23% by 2025. Teams of 7+ average 16.7 claims per patent vs. 11.6 for solo inventors.\",\"url\":\"https://patentworld.vercel.app/chapters/inv-team-size/\",\"position\":17},{\"@type\":\"ScholarlyArticle\",\"name\":\"Domestic Geography\",\"description\":\"California accounts for 23.6% of all US patent grants, producing 992,708 patents -- more than the bottom 30 states combined. States exhibit distinctive specialization: Michigan devotes 20.1% to Mechanical Engineering vs. California's 65.1% in Physics and Electricity.\",\"url\":\"https://patentworld.vercel.app/chapters/geo-domestic/\",\"position\":18},{\"@type\":\"ScholarlyArticle\",\"name\":\"International Geography\",\"description\":\"Japan leads foreign filings with 1.45 million US patents, while China grew from 299 filings in 2000 to 30,695 in 2024. The US leads with approximately 164,000 patents granted cumulatively during the 2020s (by assignee country) and 18.4 average claims, while rapidly growing origins exhibit lower claims, suggesting a quality-quantity tradeoff.\",\"url\":\"https://patentworld.vercel.app/chapters/geo-international/\",\"position\":19},{\"@type\":\"ScholarlyArticle\",\"name\":\"Organizational Mechanics\",\"description\":\"11 of 20 major filers keep exploration below 5%. Balanced firms produce blockbusters at 2.3x the rate of specialists. 618 organizations form distinct industry clusters in the co-patenting network.\",\"url\":\"https://patentworld.vercel.app/chapters/mech-organizations/\",\"position\":20},{\"@type\":\"ScholarlyArticle\",\"name\":\"Inventor Mechanics\",\"description\":\"632 prolific inventors form 1,236 co-invention ties. 143,524 inventor movements (consecutive patents at different assignees within 5 years) flow among 50 organizations. International mobility rose from 1.3% to 5.1%, with the US involved in 77.6% of all cross-border flows.\",\"url\":\"https://patentworld.vercel.app/chapters/mech-inventors/\",\"position\":21},{\"@type\":\"ScholarlyArticle\",\"name\":\"Geographic Mechanics\",\"description\":\"International co-invention increased from 1.0% in 1976 to 10.0% in 2025 (through September). US-China co-invention grew from 77 patents in 2000 to 2,749 in 2024.\",\"url\":\"https://patentworld.vercel.app/chapters/mech-geography/\",\"position\":22},{\"@type\":\"ScholarlyArticle\",\"name\":\"3D Printing \u0026 Additive Manufacturing\",\"description\":\"Top-four-firm concentration in 3D printing patents declined from 36% in 2005 to 11% by 2024, as the expiration of key FDM patents in 2009 opened the field to broad-based competition. Later entrants (2010s cohort) patent at 11.2 patents per year compared to 8.3 for 1990s entrants.\",\"url\":\"https://patentworld.vercel.app/chapters/3d-printing/\",\"position\":23},{\"@type\":\"ScholarlyArticle\",\"name\":\"Agricultural Technology\",\"description\":\"Agricultural technology patent velocity nearly quadrupled from 7.4 patents per year (1970s entrants) to 32.9 (2000s entrants), coinciding with the precision agriculture revolution. Top-four concentration declined from 46.7% in 2014 to 32.8% by 2025.\",\"url\":\"https://patentworld.vercel.app/chapters/agricultural-technology/\",\"position\":24},{\"@type\":\"ScholarlyArticle\",\"name\":\"Artificial Intelligence\",\"description\":\"AI patent grants grew 5.7-fold from 5,201 in 2012 to 29,624 in 2023, reaching 9.4% of all US patent grants. IBM leads with 16,781 AI patents, followed by Google (7,775) and Samsung (6,195).\",\"url\":\"https://patentworld.vercel.app/chapters/ai-patents/\",\"position\":25},{\"@type\":\"ScholarlyArticle\",\"name\":\"Autonomous Vehicles \u0026 ADAS\",\"description\":\"Autonomous vehicle patent velocity rose from 15.9 patents per year (1990s entrants) to 28.6 (2010s entrants), a 1.8-fold increase. Subfield diversity reached near-maximum entropy of 0.97 by 2025. Toyota, Honda, Ford, and Waymo lead the field.\",\"url\":\"https://patentworld.vercel.app/chapters/autonomous-vehicles/\",\"position\":26},{\"@type\":\"ScholarlyArticle\",\"name\":\"Biotechnology \u0026 Gene Editing\",\"description\":\"Biotechnology achieved the lowest top-four concentration among all advanced technology domains studied, declining from 13.5% in 2007 to 4.6% by 2025. Subfield diversity tripled from 0.32 in 1976 to 0.94 by 2025, reflecting successive waves from recombinant DNA to CRISPR-Cas9.\",\"url\":\"https://patentworld.vercel.app/chapters/biotechnology/\",\"position\":27},{\"@type\":\"ScholarlyArticle\",\"name\":\"Blockchain \u0026 Decentralized Systems\",\"description\":\"Blockchain patent filings peaked in 2022 and subsequently declined, the only advanced technology domain in the study to reverse course. Top-four concentration rose to 26.3% during the 2018 boom before declining to 14.0% by 2024.\",\"url\":\"https://patentworld.vercel.app/chapters/blockchain/\",\"position\":28},{\"@type\":\"ScholarlyArticle\",\"name\":\"Cybersecurity\",\"description\":\"Cybersecurity top-four concentration declined from 32.4% in 1980 to 9.4% by 2025, reflecting broad-based entry across the field. Patent velocity reached 105.8 patents per year for 2010s entrants, a 1.4-fold increase over 1970s entrants. Network security surpassed cryptography as the dominant subfield around 2003.\",\"url\":\"https://patentworld.vercel.app/chapters/cybersecurity/\",\"position\":29},{\"@type\":\"ScholarlyArticle\",\"name\":\"Digital Health \u0026 Medical Devices\",\"description\":\"Digital health patent velocity jumped 3.4-fold from 22.5 patents per year (1970s entrants) to 77.5 (2010s entrants). Philips (2,909 patents), Medtronic (2,302), and Intuitive Surgical (1,994) lead the field. Subfield diversity rose from 0.48 in 1976 to 0.92 by 2025.\",\"url\":\"https://patentworld.vercel.app/chapters/digital-health/\",\"position\":30},{\"@type\":\"ScholarlyArticle\",\"name\":\"Green Innovation\",\"description\":\"Green patents show a 1.8-fold velocity increase from 1970s to 2000s entrants (68 to 122 patents per year). Battery and EV patents reached 7,363 and 5,818 grants respectively by 2024, surpassing renewable energy at 3,453. Samsung (13,771), Toyota (12,636), and GE (10,812) lead.\",\"url\":\"https://patentworld.vercel.app/chapters/green-innovation/\",\"position\":31},{\"@type\":\"ScholarlyArticle\",\"name\":\"Quantum Computing\",\"description\":\"Quantum computing remains among the most concentrated advanced technology domains alongside agricultural technology, with the top four firms holding 28.4% of patents in 2025 (through September), down from 76.9% in 2003. It is the only domain where early entrants (1990s cohort) patent faster than later entrants, reflecting high hardware IP barriers.\",\"url\":\"https://patentworld.vercel.app/chapters/quantum-computing/\",\"position\":32},{\"@type\":\"ScholarlyArticle\",\"name\":\"Semiconductors\",\"description\":\"Semiconductor patents uniquely exhibit rising concentration, with top-four-firm share increasing from 11.3% in 1977 to 32.6% in 2023 — the only advanced technology domain showing sustained consolidation. Entry velocity plateaued at 197 patents per year for both 1990s and 2010s cohorts.\",\"url\":\"https://patentworld.vercel.app/chapters/semiconductors/\",\"position\":33},{\"@type\":\"ScholarlyArticle\",\"name\":\"Space Technology\",\"description\":\"Space technology top-four concentration fluctuated between 4.9% and 36.7%, reflecting the transition from government-dominated to commercial-driven innovation. Boeing, ViaSat, and Lockheed Martin lead, with satellite communications now the dominant subfield.\",\"url\":\"https://patentworld.vercel.app/chapters/space-technology/\",\"position\":34}]},{\"@context\":\"https://schema.org\",\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://patentworld.vercel.app\"}]}]"])</script><script>self.__next_f.push([1,"18:[]\n"])</script><script>self.__next_f.push([1,"0:[\"$\",\"$L5\",null,{\"buildId\":\"FO03nZyY7zualjcsVMF1Y\",\"assetPrefix\":\"/patentworld\",\"urlParts\":[\"\",\"chapters\",\"biotechnology\",\"\"],\"initialTree\":[\"\",{\"children\":[\"chapters\",{\"children\":[\"biotechnology\",{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],\"initialSeedData\":[\"\",{\"children\":[\"chapters\",{\"children\":[\"biotechnology\",{\"children\":[\"__PAGE__\",{},[[\"$L6\",[\"$\",\"$L7\",null,{\"props\":{\"params\":{},\"searchParams\":{}},\"Component\":\"$8\"}],null],null],null]},[[null,[[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"$9\"}}],[\"$\",\"$La\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"chapters\",\"children\",\"biotechnology\",\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$Lb\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"notFoundStyles\":\"$undefined\"}]]],null],null]},[[null,[\"$\",\"div\",null,{\"className\":\"relative\",\"children\":[[\"$\",\"$Lc\",null,{}],[\"$\",\"div\",null,{\"className\":\"lg:ml-64\",\"children\":[\"$\",\"div\",null,{\"className\":\"mx-auto max-w-5xl px-4 py-12 lg:px-8\",\"children\":[[\"$\",\"$Ld\",null,{}],[\"$\",\"$Le\",null,{}],[\"$\",\"article\",null,{\"itemScope\":true,\"itemType\":\"https://schema.org/ScholarlyArticle\",\"children\":[\"$\",\"$La\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"chapters\",\"children\"],\"error\":\"$f\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$Lb\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"notFoundStyles\":\"$undefined\"}]}],[\"$\",\"p\",null,{\"className\":\"mt-12 border-t pt-4 text-xs text-muted-foreground\",\"children\":\"Data coverage: January 1976 through September 2025. All 2025 figures reflect partial-year data.\"}]]}]}]]}]],null],null]},[[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/patentworld/_next/static/css/68682e2a9cafe58c.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}]],[\"$\",\"html\",null,{\"lang\":\"en\",\"suppressHydrationWarning\":true,\"className\":\"__variable_b4e6c6 __variable_efa179 __variable_149e4c\",\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"meta\",null,{\"name\":\"google-site-verification\",\"content\":\"El4nzV7RYgAGJl6KI74cX-Hj3LNkzQamTYyudkoF0es\"}],[\"$\",\"meta\",null,{\"name\":\"msvalidate.01\",\"content\":\"AFA1EA03BEF26C7EAF46830EC6A92A41\"}],[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"$10\"}}]]}],[\"$\",\"body\",null,{\"className\":\"font-sans\",\"children\":[\"$\",\"$L11\",null,{\"attribute\":\"class\",\"defaultTheme\":\"system\",\"enableSystem\":true,\"children\":[[\"$\",\"a\",null,{\"href\":\"#main-content\",\"className\":\"sr-only focus:not-sr-only focus:fixed focus:top-1 focus:left-1 focus:z-[80] focus:rounded-md focus:bg-primary focus:px-4 focus:py-2 focus:text-primary-foreground focus:text-sm\",\"children\":\"Skip to content\"}],[\"$\",\"$L12\",null,{}],[\"$\",\"$L13\",null,{}],[\"$\",\"main\",null,{\"id\":\"main-content\",\"className\":\"min-h-screen\",\"children\":[\"$\",\"$La\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\"],\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$Lb\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"title\",null,{\"children\":\"404: This page could not be found.\"}],[\"$\",\"div\",null,{\"style\":{\"fontFamily\":\"system-ui,\\\"Segoe UI\\\",Roboto,Helvetica,Arial,sans-serif,\\\"Apple Color Emoji\\\",\\\"Segoe UI Emoji\\\"\",\"height\":\"100vh\",\"textAlign\":\"center\",\"display\":\"flex\",\"flexDirection\":\"column\",\"alignItems\":\"center\",\"justifyContent\":\"center\"},\"children\":[\"$\",\"div\",null,{\"children\":[[\"$\",\"style\",null,{\"dangerouslySetInnerHTML\":{\"__html\":\"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}\"}}],[\"$\",\"h1\",null,{\"className\":\"next-error-h1\",\"style\":{\"display\":\"inline-block\",\"margin\":\"0 20px 0 0\",\"padding\":\"0 23px 0 0\",\"fontSize\":24,\"fontWeight\":500,\"verticalAlign\":\"top\",\"lineHeight\":\"49px\"},\"children\":\"404\"}],[\"$\",\"div\",null,{\"style\":{\"display\":\"inline-block\"},\"children\":[\"$\",\"h2\",null,{\"style\":{\"fontSize\":14,\"fontWeight\":400,\"lineHeight\":\"49px\",\"margin\":0},\"children\":\"This page could not be found.\"}]}]]}]}]],\"notFoundStyles\":[]}]}],[\"$\",\"$L14\",null,{}],[\"$\",\"footer\",null,{\"className\":\"border-t mt-20\",\"children\":[\"$\",\"div\",null,{\"className\":\"mx-auto max-w-7xl px-4 py-8 lg:px-8\",\"children\":[[\"$\",\"div\",null,{\"className\":\"flex flex-col items-center justify-between gap-4 sm:flex-row\",\"children\":[[\"$\",\"p\",null,{\"className\":\"text-sm text-muted-foreground\",\"children\":[\"Data from\",\" \",[\"$\",\"a\",null,{\"href\":\"https://patentsview.org\",\"target\":\"_blank\",\"rel\":\"noopener noreferrer\",\"className\":\"underline hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm\",\"children\":\"PatentsView\"}],\" \",\"(USPTO), accessed Feb 2026. Coverage: 1976–Sep 2025.\"]}],[\"$\",\"div\",null,{\"className\":\"flex items-center gap-4 text-sm text-muted-foreground\",\"children\":[[\"$\",\"$L15\",null,{\"href\":\"/methodology/\",\"className\":\"hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm\",\"children\":\"Methodology\"}],[\"$\",\"$L15\",null,{\"href\":\"/about/\",\"className\":\"hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm\",\"children\":\"About\"}],[\"$\",\"$L15\",null,{\"href\":\"/explore/\",\"className\":\"hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm\",\"children\":\"Explore\"}],[\"$\",\"$L15\",null,{\"href\":\"/about/#faq\",\"className\":\"hover:text-foreground focus:outline-none focus:ring-2 focus:ring-primary rounded-sm\",\"children\":\"FAQ\"}]]}]]}],[\"$\",\"p\",null,{\"className\":\"text-xs text-muted-foreground/70\",\"children\":[\"© \",2026,\" Saerom (Ronnie) Lee. Content licensed under\",\" \",[\"$\",\"a\",null,{\"href\":\"https://creativecommons.org/licenses/by/4.0/\",\"target\":\"_blank\",\"rel\":\"noopener noreferrer\",\"className\":\"underline hover:text-foreground\",\"children\":\"CC BY 4.0\"}],\".\"]}]]}]}]]}]}]]}]],null],null],\"couldBeIntercepted\":false,\"initialHead\":[null,\"$L16\"],\"globalErrorComponent\":\"$17\",\"missingSlots\":\"$W18\"}]\n"])</script><script>self.__next_f.push([1,"16:[[\"$\",\"meta\",\"0\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}],[\"$\",\"meta\",\"1\",{\"charSet\":\"utf-8\"}],[\"$\",\"title\",\"2\",{\"children\":\"Biotech Patents Transformed by Gene Editing | PatentWorld\"}],[\"$\",\"meta\",\"3\",{\"name\":\"description\",\"content\":\"Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation.\"}],[\"$\",\"link\",\"4\",{\"rel\":\"author\",\"href\":\"https://www.saeromlee.com\"}],[\"$\",\"meta\",\"5\",{\"name\":\"author\",\"content\":\"Saerom (Ronnie) Lee\"}],[\"$\",\"meta\",\"6\",{\"name\":\"keywords\",\"content\":\"patents,innovation,USPTO,patent data,biotech patents,gene editing patents,CRISPR patents,recombinant DNA,enzyme engineering,nucleic acid detection\"}],[\"$\",\"meta\",\"7\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"8\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-image-preview:large, max-snippet:-1\"}],[\"$\",\"link\",\"9\",{\"rel\":\"canonical\",\"href\":\"https://patentworld.vercel.app/chapters/biotechnology/\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:title\",\"content\":\"Biotech Patents Transformed by Gene Editing | PatentWorld\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:description\",\"content\":\"Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation.\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:url\",\"content\":\"https://patentworld.vercel.app/chapters/biotechnology/\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:site_name\",\"content\":\"PatentWorld\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image\",\"content\":\"https://patentworld.vercel.app/og/home.png\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:width\",\"content\":\"1200\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:height\",\"content\":\"630\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:image:alt\",\"content\":\"Biotechnology \u0026 Gene Editing — PatentWorld\"}],[\"$\",\"meta\",\"18\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary_large_image\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"Biotech Patents Transformed by Gene Editing | PatentWorld\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"Biotechnology patents cover gene editing, CRISPR, enzyme engineering, and nucleic acid detection. Explore 50 years of molecular biology innovation.\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://patentworld.vercel.app/og/home.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/patentworld/icon?d08d85312a94b8a2\",\"alt\":\"$undefined\",\"type\":\"image/png\",\"sizes\":\"32x32\"}],[\"$\",\"meta\",\"24\",{\"name\":\"next-size-adjust\"}]]\n"])</script><script>self.__next_f.push([1,"6:null\n"])</script></body></html>